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kDa  kilodalton 
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PCR  polymerase chain reaction 
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1. Introduction 
 
1.1. Cell signaling 
 
The ability of one cell to influence the behavior of another cell is achieved through 
cell communication, termed cell signaling. These communication mechanisms 
depend heavily on extracellular signal molecules that are produced from the cells 
to signal to their neighbors or cells further away. Mostly the communication does 
not only consist of one signal, but whole networks of signaling were developed in 
multicellular organisms. Over the time several different signaling pathways have 
been developed, as for example the Notch-, the Hedgehog-, the BMP-, and the 
Wnt signaling pathway. At the end of each intracellular signaling pathway are 
target proteins, which are altered when the pathway is active and change the 
behavior of the cell. Moreover, a crosstalk between the different pathways occurs, 
what leads to a big network of signals and a tight regulation within a cell. 
Disturbance of the balanced systems often leads to diseases, as for example 
cancer. In the following I will concentrate on the Wnt signaling pathway. 
 
 
1.2. Overview of the different Wnt signaling pathways 
 
The Wnt signaling consists of three different pathways. The classical Wnt/β-
catenin pathway, termed canonical Wnt pathway, the frizzled regulated planar cell 
polarity pathway (PCP), and the Wnt/Ca2+ pathway (Kuhl 2000; Wang 2003). The 
PCP pathway involves the small GTPases rho and cdc42 as well as the Jun-N-
terminal kinase (JNK) (Weber 2000) and regulates Drosophila development 
independently of β-catenin (David 2002). The mechanism is not completely 
understood, but it seems that it is not a linear signaling pathway from the receptor 
frizzled (Fz) through a downstream cytoplasmic protein Dishevelled (Dsh), to 
Introduction  2 
 
 
 
tissue specific proteins, but that the signaling involves asymmetric distribution of 
Fz and Dsh and is functioning through a feedback loop (David 2002).  
In the Wnt/Ca2+ pathway, Fz appears to act through heterotrimeric guanine 
nucleotide-binding proteins (G proteins) (Slusarski 1997) and seems to activate 
phospholipase C (PLC) and phosphodiesterase (PDE) (Ahumada 2002), which 
lead to increased concentrations of free intracellular calcium and to decreased 
intracellular concentrations of cyclic guanosine monophosphate (cGMP). 
The canonical Wnt cascade plays a critical role in many developmental processes. 
It has been implicated in the development of B and T cells (Okamura 1998; Reya 
2000) and in the self-renewal of haematopoietic stem cells (HSC) (Reya 2003). 
The transcription factors LEF/TCF mediate a nuclear response to Wnt signals by 
interacting with β-catenin. After a Wnt signal, β-catenin is stabilized and 
transported to the nucleus, and is binding to the LEF/TCF proteins  bnto turn on 
target genes. The following overview delineates the function of the canonical Wnt 
pathway, respectively of LEF/TCF. 
 
 
1.3. The canonical Wnt Cascade 
 
In unstimulated cells, β-catenin is in a big cytoplasmic complex together with the 
tumor suppressor adenomatous polyposes coli (APC), the constitutively active 
kinase Glycogen synthase kinase 3β (GSK-3β), and Axin. In this complex, β-
catenin is captured and subjected to phosphorylation by GSK-3β at four N-terminal 
serine and threonine residues (Ikeda 1998). The phosphorylation of β-catenin is 
recognized by different proteins like Slimb/TrcP and getting conveyed to ubiquitin 
conjugating enzymes, which mark β-catenin for degradation (Jiang 1998; 
Marikawa 1998). β-catenin is rapidly degraded via the ubiquitin-proteasome 
pathway (Aberle 1997). The Wnt family members are ligands of the Frizzled (Fz) 
family of serpentine receptors (Bhanot 1996). Wnt proteins comprise a large family 
of so far 19 identified family members that have been found in round worms, 
insects, and vertebrates (Sidow 1992). Wnt proteins are secreted glycoproteins 
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that have been shown to be associated with the cell surface or extracellular matrix 
of secreting cells, making a local activity through its biochemical properties most 
likely (Bradley 1990; Papkoff 1990). They are involved in a number of 
developmental and physiologic processes. The Low-density lipoprotein receptor-
related proteins (LRP) can bind together with Fz to the Wnt proteins, thus 
activating the Wnt cascade (Pinson 2000; Tamai 2000). As a consequence of Wnt 
signal, GSK-3β is inhibited by the cytoplasmic protein Dishevelled (Dsh) 
(Noordermeer 1994; Kishida 1999; Smalley 1999; Itoh 2000), preventing the 
phosphorylation of β-catenin and its degradation. The so stabilized β-catenin is 
transferred into the nucleus where it can interact with the nuclear mediators of Wnt 
signaling, the LEF/TCF proteins and turn on Wnt target genes by interaction with 
the mediators (Hsu 1998). Another interaction that was shown to occur in the 
nucleus is the binding of β-catenin to the BCL9/ Pygopus (Pyg) complex what 
might help to stabilize β-catenin. 
In the absence of a Wnt signal, LEF/TCF proteins cannot activate target genes of 
the Wnt pathway, moreover they can interact with Groucho, a co-repressor and 
actively repress the transcription of genes (Figure1). 
 
 
1.4. LEF/TCF protein family 
 
The first members of the LEF/TCF family to be identified were T cell factor 1 (Tcf1) 
(Oosterwegel 1991; van de Wetering 1991) and Lymphoid enhancer factor 1 (Lef1) 
(Travis 1991; Carlsson 1993). Proteins of the LEF/TCF family share an 80-amino-
acid high mobility group (HMG) box. It was shown that the HMG box can bind to 
DNA as a monomer in a sequence specific manner (Giese 1991; Travis 1991). 
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Figure 1. Schematic view of the canonical Wnt pathway.
 
Other features of LEF-1 are the β-catenin binding domain (βBD), through which 
the interaction with β-catenin is achieved, and the context dependent activation 
domain (CAD) that can interact for example with the Ally of AML-1 and LEF-1 
(ALY), an ubiquitously expressed nuclear protein that was shown to be necessary 
for the T cell receptor α (TCRα) enhancer function (Bruhn 1997) (Figure2). 
The LEF/TCF family members are expressed in a great variety of tissues such as 
immature T and B cells of adult mice and in the neural crest, mesencephalon, 
tooth germs, whisker follicles, and other sites during embryogenesis. It was shown 
that LEF-1 has an architectural function and can interact with different proteins 
what results in either activation or repression of target genes. For the activating 
effect,  the  LEF/TCF  family  members  mostly  interact  with  β-catenin  to  turn  on  Wnt 
target genes what makes them for this regulation a member of the Wnt signaling 
pathway. In a distinct number of cases LEF-1 can also positively regulate target 
genes without the help of β-catenin, thus acting independently of the Wnt pathway, 
as it was shown for example for the regulation of TCRα by LEF-1 (Travis 1991). 
Introduction  5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Schematic diagram of LEF-1. 
The most important elements of LEF-1 are indicated. The β-catenin interaction domain (βBD), the
context dependent activation domain (CAD), and the high mobility group (HMG). ALY can bind to
LEF-1 via the CAD domain, β-catenin, a coactivator of LEF-1 interacts with the βBD domain.
Groucho, a corepressor binds to part of the CAD domain. 
But LEF/TCF proteins can also actively repress transcription. This was first 
observed with experiments in Drosophila and Xenopus, showing that in the 
absence of a Wnt/Wg signal the repression of Ultrabithorax (Ubx) and Siamois is 
released by mutating the LEF/TCF consensus sites in their transcriptional control 
elements (Brannon 1997; Riese 1997; Bienz 1998). There are some co-repressors 
known to directly interact with LEF/TCF proteins that help to repress target genes. 
One of them is Groucho that also interacts with several other DNA-binding proteins 
such as Hairy, Engrailed, and Dorsal (Cavallo 1998; Fisher 1998; Levanon 1998; 
Roose 1998). Groucho binds to part of the CAD domain of LEF-1, making it 
possible that its binding can occur at the same time as β-catenin binding leading to 
a repressive effect in the context of a Wnt signal. Repression through LEF-1 and 
β-catenin interaction was shown for E-cadherin without the help of any co-
repressors (Jamora 2003). Nevertheless it seems to be more likely, that the main 
mechanism for repression is mediated without the help of β-catenin. The 
contribution of β-catenin to the downregulation might be sometimes necessary for 
the induction of Groucho or other co-repressors, but then β-catenin is not 
conducive to the repressive effect itself as it was shown recently in the analysis of 
They could provide evidence, that Groucho is localized to the same areas as β-
catenin before the formation of the bud. At later stages of bud maturation, the 
expression pattern of Groucho and β-catenin are not overlapping any more. In this 
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stage Groucho is expressed only in areas where no β-catenin is expressed and 
vice versa.  
Taking together, the reports about the mechanism of repression through LEF-1 are 
contradictionary, and no main pathway was discovered yet. Thus, for the 
repressive effect of LEF/TCF proteins there are still a lot of questions to be 
answered. 
 
 
1.5. Haematopoiesis 
 
All of the mature blood cells in the body are generated from a relatively small 
number of haematopoietic stem cells (HSCs) and progenitors (Weissman 2000). In 
the mouse, a single HSC can reconstitute the entire haematopoietic system for the 
natural lifespan of the animal (Osawa 1996). HSCs generate the multiple 
haematopoietic lineages through a series of intermediate progenitors. Those are 
the common lymphoid progenitors (CLPs) that give rise to natural killer cells (NK), 
T cells, and B cells, and the common myeloid progenitors (CMPs), which can 
generate monocytes, granulocytes, megacaryothytes, and erythrocytes (Kondo 
1997; Akashi 2000). Out of the CMPs develop more specialized progenitors, that 
are further restricted to a number and type of cell lineages that they can generate. 
These are the granulocyte/monocyte progenitors (GMP), which give raise to the 
granulocytes and monocytes, and the megacarythrocyte/erythrocyte progenitors 
(MEP), which can develop to megacarythrocytes and erythrocytes (Akashi 2000). 
Further downstream of the CLPs, the NK cells and the pro T and pro B cells 
develop. Terminally differentiated cells are produced that cannot divide any longer 
and undergo apoptosis after days to decades depending on their cell type (Figure 
3) 
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Figure 3. Haematopoiesis. 
Long term haematopoietic stem cells (LT-HSC) give rise to short term (ST) HSCs. Due to different
stimuli they either become common lymphoid progenitors (CLP) or common myeloid progenitors
(CMP). Downstream of CLPs the cells either develop to natural killer cells (NK), to B or T cells.
The CMPs give rise to more specialized progenitors, granulocyte/monocyte progenitors (GMP)
and megakaryocyte/erythrocyte progenitors (MEP). Those finally differentiate to granulocytes,
monocytes, megakaryocytes, and erythrocytes.  
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1.6. Role of the Wnt pathway in haematopoietic stem cells 
 
Haematopoietic stem cells (HSCs) are pluripotent cells with the capacity to 
produce cells of all blood lineages over the whole life span. For that, the cells need 
a balance between their plasticity that is the production of progenitor cells, which 
generate specific blood lineages, and their own self-renewal. Until today not much 
is known about the mechanisms underlying both processes. It was shown that 
Wnt5a and Wnt10b are expressed in the murine yolk sac and other 
microenvironments of haematopoietic stem cells, such as the microenvironment of 
the fetal liver (Austin 1997). Furthermore Wnt5a is also expressed in fetal liver 
stromal cells. These findings together with the fact that Wnt expression of HSCs 
stimulates their proliferation (Austin 1997; Van den Berg 1998), suggested that the 
Wnt signaling is involved either in the cell fate decision or in the process of self-
renewal. Recently more evidence could be provided, showing that the Wnt 
signaling is most likely involved in the self-renewal process of the HSCs (Reya 
2003). HSC cells were sorted using cells of H2K-BCL-2 transgenic mice, to reduce 
the effects of pro-differentiation stimuli necessary for the infection prior to the 
experiment readout. The sorted HSC cells were infected with a retrovirus carrying 
either β-catenin-IRES-GFP or IRES-GFP alone for control, and then again sorted, 
this time for GFP expression. It was shown that almost twice as many cells 
expressing β-catenin are in the active cell cycle than cells infected with the control. 
The complete withdrawal of growth factors showed, that Wnt signaling increases 
the long-term growth, as the β-catenin expressing cells could still proliferate for 
more than four weeks, whereas the control cells showed only minimal growth for 
less than two weeks. At the same time the cells were not starting to upregulate 
lineage specific markers, showing that the majority of the cells retained the 
phenotype of HSCs. To control if the cells were still able to give rise to the different 
lymphoid lineages, retrovirally transduced cells were transplanted into lethally 
irradiated mice in limiting numbers and the mice were analyzed after 11 weeks. 
Clear reconstitution of the myeloid, T and B lineages could be achieved using the 
cells infected with a β-catenin expressing virus, whereas the control cells failed to 
reconstitute all lineages. They also tested if LEF/TCF proteins are activated in 
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HSC cells, by infection of the cells with destabilized GFP driven by the LEF/TCF 
reporter (TOP-dGFP) or by the mutated form of the reporter (FOP-dGFP) as a 
control. The infected HSC cells were transplanted into lethally irradiated mice and 
the bone marrow was studied for GFP expression 14 days post transplantation. 
The bone marrow transplanted with β-catenin expressing cells showed a large 
number of GFP positive cells derived from the donor whereas host cells and 
transplanted control cells were only low in GFP expression. This showed that 
HSCs in vivo normally signal through LEF/TCF elements. The requirement of an 
intact Wnt signal for HSCs was tested with two different setups. First the soluble 
form of the frizzled cysteine-rich domain (CRD) that inhibits binding of Wnt proteins 
to the frizzled receptor was added as an IgG fusion (CRD-IgG) to wildtype HSCs in 
culture or IgG alone as a control. The CRD domain inhibited growth by four fold 
whereas the control did not change the proliferation, indicating that indeed the Wnt 
signaling is necessary for proliferation. As a second evidence for this, the 
independent inhibitor axin was ectopically expressed in HSCs. Axin increases β-
catenin degradation and leads to a reduced Wnt signal. Cells  infected with an axin 
expressing retrovirus could be shown to have a seven fold reduced growth 
potential, and a decreased cell survival potential compared to control cells. In 
addition to those findings, genes known to be involved in self-renewal as HoxB4 
and Notch1 were tested for regulation after infection of HSCs with β-catenin. 
HoxB4 and Notch1 were found to be upregulated in HSCs overexpressing 
β−catenin compared to control cells. Those findings indicate strongly that a Wnt 
signal is needed for cell survival and proliferation of HSCs, but it does not give 
signals for differentiation.  
 
 
1.7. Role of the Wnt signaling in B cell development 
 
The B cell differentiation is characterized by the rearrangement of the 
immunoglobin genes and by the expression of different molecules in the cell and 
on its surface. The first B cells develop in the fetal liver, whereas after birth the 
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process is taking place in the bone marrow. The differentiation is a tightly 
regulated process that is strongly depending on the expression of certain genes. 
The earliest B cell precursors are derived from pluripotent stem cells. Those cells 
express AA4.1, B220, and CD43 at their surface and belong to the fraction A of 
pre-B cells, also called preBI cells (Hardy 1991; Rolink 1993; Li 1996). They go on 
in differentiation to fraction B cells, so called pro-B cells, which express B220, 
CD43, and the heat stable antigen (HAS) on the surface. In this phase the 
rearrangement of the immunoglobin D-JH occurs. In the next stage (fraction C), 
cells express BP-1 on their surface and VH-DJH gene recombination takes place. 
Cells of fraction B and C express the immunoglobulin surrogate light chain genes, 
λ5 and VpreB. After rearrangement of the light chain gene, the heavy and light 
chains are expressed on the surface together with the signal transduction 
elements Igα (mb-1) and Igβ (B-29), forming together the pre-B cell complex (pre 
BCR). Now the cell is in the pre-B cell stage where the last H elements have been 
rearranged, and the L chains are starting to get rearranged what results in the 
expression of IgM on the surface. As soon as the cells express IgM, they are 
called immature B cell. Those cells migrate now to the periphery, express IgD and 
become fully capable of responding to antigens (mature B cells). Many genes are 
involved in the process of B cell development, whereby the exact function of them 
has been subject to intensive studies. LEF-1 is known to be expressed in 
transformed pre-B cell lines but not in mature B cell lines (Travis 1991). The other 
family members of the LEF/TCF family are not found to be expressed in any stage 
of the B cell development. Only little is known about the influence of Wnt signaling 
on B cell development. The first evidence that Wnt might play a critical role came 
from the finding, that some leukemic B cell lines overexpress a novel Wnt protein, 
Wnt 16 (McWhirter 1999). The exact expression pattern of the Wnt proteins and 
LEF-1 in B cells and the role of Wnt signaling and LEF-1 in the development 
remained unclear. Recently the effects of LEF-1 on B cell development were 
subject to an intensive analysis (Reya 2000). First the precise pattern of LEF-1 in 
developing B cells was studied. It could be shown by visualizing the lacZ gene that 
was inserted into one allele of the Lef1 locus by homologous recombination 
(Galceran 2000), that LEF-1 is expressed during early B cell development in the 
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fetal liver and adult bone marrow. The upregulation occurs in fraction B pro-B cells 
and LEF-1 can also be detected in fraction C cells. There is no LEF-1 expression 
found in IgM-positive B cells from the adult spleen or adult bone marrow. To test 
for a correlation between the expression pattern and the function, fetal liver of 
Lef1-/- embryos and perinatal bone marrow was analyzed, as an analysis of older 
mice is not possible due to the early death of Lef1-/- mice. The number of B220+ 
cells was reduced by more than two fold and was even more obvious after 
excluding the dying and dead cells. To specify the stage of the cells, B220+ 
positive cells were tested for other surface markers and it could be shown, that the 
majority of the B220+ cells were also CD43+, placing them in the pro-B cell 
compartment. To test if LEF-1 deficiency results in a differentiation defect, they 
tested bone marrow of mice at postnatal day 13 (P13) for the ratio of IgM- to IgM+ 
B lymphocytes. Although the total number of the cells was reduced as shown 
before, the ratio remained still the same and there were no defects in 
rearrangement of the immunoglobulin heavy and light chains occurring. Those 
findings were also confirmed with adoptive transfer experiments where the mutant 
B cells behaved like wildtype cells in a wildtype environment. They went on to 
analyze if the reduced number of B220+ cells is due to reduced cell survival. With 
TUNNEL assay and Annexin V staining it could be shown that indeed the B220+ 
cells of Lef1-/- mice die at an up to 20-fold higher frequency. As a cause for the 
reduced survival, Reya and coworkers were analyzing the expression level of 
several genes known to be involved in apoptosis. Whereas the levels of Bcl-2, Bcl-
x, and p53 remained unchanged in sorted pro-B cells (fraction B) of Lef1-/- mice 
compared to wildtype, the expression of Fas and c-myc was elevated. A second 
defect that can contribute to the reduced size of the B cell compartment is the 
diminished proliferation of the B cells. With a thymidine incorporation assay it could 
be shown, that in addition to the increased apoptosis the proliferation is 
decreased, arguing that LEF-1 has an important function for the proliferation of B 
cells. As LEF-1 and β-catenin together are members of the Wnt signaling pathway, 
they went on testing the responsiveness of B cells to Wnt stimuli. Whereas 
Wnt10B, Wnt3A, and Wnt5A were found to be expressed in bone marrow, only 
Wnt5A was expressed in the stromal cells of the bone marrow, indicating that the 
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other family members are produced by the haematopoietic cells themselves. They 
could show, that proliferation of wildtype pro-B cells is increased after LiCl 
stimulation, and that the soluble Wnt3A could stabilize β-catenin in the cells. 
Furthermore comparing the responsiveness of wildtype and Lef1-/- cells to Wnt3A 
stimulation revealed the LEF-1 dependence. Only a small proportion of cells 
deficient for LEF-1 started to proliferate after Wnt3A addition whereas the majority 
of the wildtype cells were found to start dividing. Those findings taken together 
strongly indicate an essential role of Wnt signaling and LEF-1 expression for B cell 
development. 
 
 
1.8. Role of Wnt signaling in T cell development 
 
Differentiation of T cells in the thymus is a well-defined process that can be 
characterized by the expression of specific surface markers. The T cell precursors 
that migrate to the thymus express almost no surface markers typical for T cells, 
only low levels of CD4 (Wu 1991). When the precursors start to differentiate, they 
reach first a stage termed double negative (DN) stage, expressing neither CD4 nor 
CD8. This stage can be divided into four distinct differentiation stages, defined by 
the surface markers CD44 and CD25, starting up as CD44+CD25-, followed by 
CD44+CD25+. In the third phase they downregulate CD44 again (CD44-CD25+). 
During this step the Rag1 and Rag2 genes are upregulated and the T cell receptor 
(TCR) β, δ, and γ chains are rearranged (Godfrey 1994). Only if they succeed in 
rearranging the β chain they can go to the next step, downregulating CD25 again 
(CD44-CD25-) and can associate with the pre-TCRα (pTα), generating a pre-T cell 
receptor complex (Saint-Ruf 1994). The formation of the pTα complex is essential 
for the generation of α/β T cells (Mombaerts 1992). If the cells fail to rearrange the 
β chain and build the pTα complex but successfully rearrange the γ and δ chain, 
they can develop to γ/δ T cells. The differentiation of α/β cells continues with the 
upregulation of CD8, generating immature single positive (ISP) cells, followed by 
the upregulation of CD4 to double positive (DP) CD4+CD8+ cells. This stage is 
Introduction  13 
 
 
 
accompanied by the second upregulation of Rag1 and Rag2 and rearrangement of 
the TCRα locus. The majority of the cells in this differentiation stage fails to 
rearrange the TCRα locus successfully and over 90% of the cells undergo 
apoptosis. Cells that succeeded in rearranging, downregulate either the CD4 or 
the CD8 to get mature single positive (SP) CD4+CD8- or CD4-CD8+ cells (Figure 
4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Schematic overview of T cell development. 
To investigate the role of Wnt signaling in T cell development, several different 
approaches have been conducted. Many different knockout mice were created 
with adjactant rescue and overexpression studies. 
One approach to study effects of the LEF/TCF family members and the connected 
Wnt pathway on T cell development was to investigate their role by gene knockout 
experiments in mice. As the first gene of the LEF/TCF family members, LEF-1 was 
targeted with a knockout construct, leading to mice carrying a homozygous germ-
line mutation in the Lef1 gene that eliminates its protein expression and causes 
postnatal lethality (van Genderen 1994). For TCF-1 two different knockout mice 
have been made, targeting either exon V (Tcf1(V)-/-) or exon VII (Tcf1(VII)-/-) of the 
Tcf1 gene (Verbeek 1995). The Tcf1(V)-/- knockout allows the production of a 
truncated but still functional TCF-1 protein, whereas the Tcf1(VII)-/- knockout is 
seen as real knockout, where the production of a functional TCF-1 protein is 
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completely abolished. Studies of the T cell development in all three knockouts 
revealed, that there are only marginal defects visible due to the redundancy of 
LEF-1 and TCF-1 (Okamura 1998). Whereas in Lef1-/- knockout mice the T cell 
development is comparable with the one in wildtype mice, a very weak block of T 
cell development is visible in the two Tcf1-/- knockout mice. But only the crossing of 
the Lef1-/- and Tcf1(V)-/- knockout resulted in an almost complete block of the T cell 
development after the DN stage due to the redundancy of LEF-1 and TCF-1 
(Figure 5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5 adopted from Okamura 1998. Defects in T cell development in Lef1-/-/Tcf1-/- knockout 
mice.  
Flow cytometry analysis of E17.5 fetal thymic organ cultures, after seven days of culture. A strong 
block after the ISP CD8+ stage can be detected for Lef1-/-Tcf1(V)-/- double null cells, whereas only 
minor defects are seen in single knockout cells. 
 
A more precise analysis of the T cells in the DN stage with fetal thymic organ 
cultures revealed, that the double null mice have a 3-fold increase of this 
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proportion of cells. Anti-CD3ε antibody was used to test for a defect in pre-TCR 
signaling, but the treatment of fetal organic cultures revealed that even cells of the 
double null mice were able to develop to double positive CD4+CD8+ cells after 
treatment, indicating that the pre T cell receptor is not abrogated in double-
deficient animals. To test if the developmental defect is derived by the stroma or 
by the haematopoietic cells themselves, adoptive transfer experiment into SCID 
(severe combined immunodeficiency) mice were carried out. Those revealed that 
cells derived from double null mice were not capable to develop into the different 
lineages and the T cell development was also blocked compared to normal 
development of wildtype cells. Those findings indicated, that the haematopoietic 
cells themselves and not the stroma cells are due to the defects. To get an idea 
why the block in T cell development occurs, Okamura and coworkers were testing 
whether the TCRα levels or the V(D)J rearrangement are changed. The fact that 
the V(D)J recombination of other genes like TCRγ is detectable in double null 
mice, but not the one of TCRα, suggested that the expression levels of TCRα had 
to be changed. PCR reaction for TCRα out of sorted ISP CD8+ cells revealed, that 
indeed no TCRα was detectable in double null cells, leading to an explanation for 
the defects observed. 
Another knockout mouse created, was targeting the Wnt3a protein (Takada 1994). 
Interestingly, the phenotypic abnormalities seen in the Lef1-/-Tcf1(V)-/- double 
knockout resemble most of the changes detected in the Wnt3a targeted mutant 
mice, indicating that most of the defects are due to the absence of an active Wnt 
signaling. 
Overexpression of the extracellular Wnt binding domain of the Fz receptor in 
FTOC cultures using retroviral constructs producing the soluble form of the 
extracellular inhibitor of Wnt signaling was another approach studied (Staal 2001). 
It could be shown, that addition of Fz inhibited the development of T cells and 
resulted in an almost complete block of early thymocyte development, similar to 
the one seen in Lef1-/-Tcf1(V)-/- mice.  
In a subsequent study the Tcf1(VII)-/- knockout was subjected to a rescue 
experiment (Ioannidis 2001). Two different isoforms of Tcf1 were tested for 
rescuing, a full length Tcf1, including also the β-catenin interaction domain, and a 
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shorter isoform, missing the β-catenin interaction domain. Only the full length Tcf1 
could overcome the defects in T cell development, whereas the shorter form failed 
to rescue the knockout. This strongly indicates that the defects examined in the 
different LEF/TCF family member knockouts are due to the disruption of the Wnt 
signaling pathway.  
Another knockout that was created is the double knockout of Wnt1-/-Wnt4-/- (Mulroy 
2002). The phenotype of this knockout is very mild compared to the one of Lef1-/-
Tcf1(V)-/-. This is probably due to the redundancy of the Wnt proteins. It was 
shown, that at least three other family members of the Wnt proteins that could 
compensate for the two targeted ones are expressed in thymocytes. 
The studies discussed so far give proof that the proliferation of T cells is connected 
to the Wnt signaling, but it could not be shown yet, that Wnt signaling is also 
essential for the differentiation of T cells. Boehmer and coworkers (Gounari 2001) 
have been given the first hint, that this might be the case. They were examining 
the effects of overexpression of a shortened, stabilized form of β-catenin in a 
heterozygous floxed transgenic mouse (β-catThy∆ex3). They could show that 
expression of this shortened form of β-catenin in the thymus lowered on one hand 
the number of thymocytes and altered their contribution of the different stages, on 
the other hand DP CD4+CD8+ cells were produced that were lacking the 
expression of intracellular TCR-β chains. These findings indicated that a large 
proportion of the thymocytes with stabilized β-catenin proceeded to the DP stage 
in the absence of pre-TCR and TCRαβ signaling. They were also testing the 
effects of the stabilized β-catenin in RAG-2-/- mice that normally fail to develop B 
and T cells as a result of their lack of TCR chains. Thymocytes of RAG-2-/- mice 
crossed to the β-catThy∆ex3 mice were able to overcome the block at the DN3 stage 
and could develop to DP and even SP cells. Those findings suggest that the 
effects of the constitutive active β-catenin have to occur either in parallel and most 
likely independent of the pre-TCR signaling, as development is achieved in the 
absence of TCR chains. 
Furthermore could be shown, that in β-catThy∆ex3 more cells of the DN3 stage were 
in cell cycle as compared to wildtype mice. But the proportion of cells in cell cycle 
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in the DN4 stage was higher in wildtype mice than in β-catThy∆ex3. It seems that the 
β-catenin stabilization induced a greater initial activation of DN3 cells followed by 
diminished cycling. This and the finding that thymocytes of β-catThy∆ex3 mice 
undergo increased apoptosis can count for the reduced cellularity found in β-
catThy∆ex3 compared to wildtype mice.  
The studies outlined give strong indications that Wnt signaling and the LEF/TCF 
proteins play an essential role in T cell development. A Wnt signal is probably 
necessary for two events. In the first place is the Wnt stimulus essential for the 
proliferation of T cells, secondly helps a Wnt signal T cells to differentiate. 
 
 
1.9. Phenotype of the Lef1-/- knockout 
 
As described before, there was a knockout mouse generated, carrying a 
homozygous germ-line mutation in the LEF-1 gene (van Genderen 1994). The 
mice displayed a severe phenotype in the B and T cells, characterized in the 
previous paragraphs. Furthermore could defects also be detected in other tissues. 
The most obvious phenotype of the LEF-1 deficient mice was the lack of body hair 
and whiskers. The normal onset of hair follicle development is between E13 and 
E14. The development starts with the formation of small focal epidermal 
thickenings, so called placodes, in association with small dense aggregates of 
mesenchyme, called dermal papilla (Sengel 1976). The epidermal placodes grow 
into the underlying dermis and are getting characteristics of mature follicles by 
E18. In the LEF-1 deficient mice the onset of hair follicle development started 
normal, but only in reduced number, and was blocked around E17, resulting in no 
mature follicles. The skin of the mutant mice also lacked melanin and dermal fat. 
Moreover the deficient mice showed a pointed snout and were smaller in size 
compared to heterozygous and wildtype mice. Besides, no mammary glands could 
be detected in Lef1-/- mice. It could be shown that the development of mammary 
glands started in reduced number, and a developmental block occurred before 
they could mature. TMN (trigerminal nerves) neurons are located in the midbrain 
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and are derived from the neural crest (Narayanan 1978). Because a high 
concentration of LEF-1 was detected in this area, in situ analysis on TMNs was 
performed. In deficient mice the TMN was absent, indicating that LEF-1 plays also 
an essential role in the development of TMN. 
Taking the effects of LEF-1 together, it becomes clear, that LEF-1 is an essential 
gene, and mutations can lead to severe defects and even death. 
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2. Aim of the study 
 
The function of LEF-1 has been already subject of intensive studies as described 
before. Although the LEF/TCF family members have been characterized 
extensively, only little is known about events and genes downstream of LEF-1. 
Until now just few target genes of LEF-1 and its family members were identified 
and characterized. So far, most of the identified target genes are positively 
regulated by LEF-1 through its interaction with β-catenin. But it was shown before, 
that LEF-1 can also activate genes without the help of β-catenin (Travis 1991) and 
can also have repressive effects on them. In order to understand the function of 
LEF-1 and the defects following a deregulation it is important to identify further 
downstream target genes.  
Our interest is to identify LEF-1 target genes and to gain a deeper insight in the 
regulatory processes mediated through LEF-1. For that purpose we will use 
different approaches. 
In our first project, the main goal is to identify Wnt dependent LEF-1 target genes 
by controlled overexpression of a fusion of LEF-1 to the C-terminal part of β-
catenin. This is a constitutively active form of LEF-1 (CatCLEF) that we introduced 
in NIH3T3 cells. This method allows us to search predominantly for primary target 
genes as we are inducing CatCLEF for only 8 hours and to identify β-catenin 
dependent and independent target genes. 
With the second and third approach we want to explore LEF-1 dependent target 
genes in Lef1-/-Tcf1(V)-/- double knockout mice and in Lef1m5/m5 knockout mice. 
The Lef1-/-Tcf1(V)-/- double null mice have a developmental block of T cells at the 
ISP CD8+ stage. We will compare a very well defined population of T cells, ISP 
CD8+ cells, from wildtype and Lef1-/-Tcf1(V)-/- mice. This stage in T cell 
development was chosen as it is the last stage that occurs in both mice lines, in 
the wildtype and in the Lef1-/-Tcf1(V)-/- mice. This finding argues that important 
regulatory, LEF-1 dependent processes are going on in this specific cell 
population, which we hope to uncover. Another advantage of this approach is, that 
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we can minimize the unspecific effects that are due to different contributions of the 
cell compartments as the cells were sorted before the analysis. 
In a third attempt we want to take a closer look at the differences between Wnt 
dependent and Wnt independent LEF-1 target genes. The published data imply, 
that mainly the repressive function of LEF-1 is Wnt independent whereas the 
majority of activating events acts through the Wnt pathway. In our lab a knockout 
mouse line was generated, carrying a mutation in the β-catenin interaction domain 
of LEF-1, leading to a mutant LEF-1 (LEF-1m5/m5) protein that is expressed at 
normal levels but cannot interact with β-catenin any more (W. Roth, unpublished 
data). With in situ analysis a clear difference could be detected in skin between the 
Lef1-/- and Lef1m5/m5 mutant mice, indicating that in this tissue regulatory processes 
are going on that depend on LEF-1 but not on β-catenin. To analyze the target 
genes depending only on LEF-1 and those that need the interaction between LEF-
1 and β-catenin, we will compare whole skin of E16.5 embryos from wildtype, Lef1-
/-, and Lef1m5/m5 mice.  
Those three approaches will provide us with a better understanding of the complex 
regulatory processes in which LEF-1 is involved. 
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3. Materials and methods 
 
3.1. Common buffers 
 
0.5 M EDTA, pH 8.0 (ethylenediamine 
tetraacetic acid) 
Dissolve 186.1 g Na2EDTA⋅2H2O in 700 
ml H2O 
Adjust pH to 8.0 with 10 M NaOH (~50 
ml) 
Add H2O to 1 liter 
50 x TAE (Tris/acetate/EDTA) 
electrophoresis buffer 
242 g Tris base 
57.1 ml glacial acetic acid 
37.2 g Na2EDTA⋅2H2O 
H2O to 1 liter 
10 x TBE (Tris/borate/EDTA) 
electrophoresis buffer 
 
108 g Tris base (890 mM) 
55 g boric acid (890 mM) 
40 ml 0.5 M EDTA, pH 8.0 
TE (Tris/EDTA) buffer 
 
10 mM Tris−Cl, pH 8.0  
1 mM EDTA, pH 8.0 
 
 
3.2. Cell lines 
 
293T (DuBridge et al., 1987) Adenovirus 5-transformed human embryonic kid-
ney cell line 
NIH 3T3 (Jainchill er al., 1991) Fibroblastic cell line from mouse embryo 
EL4 (Gorer, 1950) Murine T cell lymphoma 
Jurkat (Gillis et al., 1980) Human acute T cell leukemia lymphoma 
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Hut78 (O’Conell et al., 1995) Human cutaneous T cell lymphoma 
J558 L (Gehring et al., 1969) Murine plasmacytoma cell line 
HeLa (Gey et al., 1952) Aneuploid, human epithelial cell line originating 
from a cervical carcinoma 
10T1/2 (Reznikoff et al., 1973) Murine mesenchymal stem cell line 
Neuro-2a (Olmsted et al., 1970) Neuronal and amoeboid stem cells 
 
3.3. Cell culture 
 
3.3.1. Culture conditions 
 
All suspension cells were cultured in filter-capped culture flasks with RPMI 1620 
media supplemented with 10% heat-inactivated fetal calf serum (FCS) and 100 
U/ml penicillin G, 100 µg/ml streptomycin, 0.3 µg/ml L-glutamine (referred to as 
RPMI complete) at 37°C in a 5% CO2-gassed atmosphere. 
Adherent cells were grown on culture tissue plates in DMEM, 1000 mg/l glucose 
media supplemented with 10% heat-inactivated FCS and 100 U/ml penicillin G, 
100 µg/ml streptomycin, 0.3 µg/ml L-glutamine (referred to as DMEM complete) at 
37°C in a 5% CO2-gassed atmosphere. 
 
 
3.3.2. Freezing, thawing, and storage of the cells 
 
The cells were frozen in their relevant media containing 10% Dimethylsulfoxide 
(DMSO) to prevent crystal formation. Cooling the cells to -80°C and lower 
temperatures had to occur slowly. Therefore they were stored in an isopropanol 
containing box at -80°C, resulting in a temperature drop of one degree per minute. 
For long term storage the cells were stored in liquid nitrogen. Thawing of cells was 
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done by submerging the frozen vial in a 37°C water bath and resuspending the cell 
pellet in pre-warmed media before transferring the cells to culture plates or flasks. 
 
 
3.4. Isolation of peripheral blood monolayer cells (PBMC) 
 
PBMCs were isolated from human whole blood. Between 100 and 200 ml of donor 
blood were taken and anticoagulant-treated with Heparin. The blood was diluted 
1:2 with Dulbecco’s phosphate buffered saline (PBS) without Ca2+ and Mg2+. 12.5 
ml of Ficoll-PaqueTM Plus (Amersham) were added to a 50 ml Falcon tube. 25 ml 
of the diluted blood were carefully layered on the Ficoll-Paque. The samples were 
centrifuged at 400 x g for 30 minutes at room temperature without brake. The 
lymphocyte layer was transferred to a clean 50 ml Falcon tube. Three volumes of 
PBS were added and cells were resuspended by gently drawing them in and out of 
a Pasteur pipette. They were centrifuged at 100 x g for 10 minutes at room 
temperature with brake. The supernatant was removed and the lymphocytes were 
resuspended in 6 ml PBS, followed by another centrifugation step at 100 x g for 10 
minutes with brake. The supernatant was removed again and the lymphocytes 
were resuspended in RPMI complete complemented with non essential amino 
acids (Gibco) and additional 2 mM glutamine and left over night in a culture plate 
to allow macrophages to attach. The following day the lymphocytes were counted 
and plated onto new plates. For stimulation Phytohemaglutamin-P (PHA-P) was 
added to a final concentration of 5 µg/ml. 
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3.5. Transfections 
 
3.5.1. Adherent cells 
 
Adherent cells were transfected using calcium phosphate.  
Cells were trypsinised and counted. Between 1.75 x 105 (for NIH 3T3) and 3.25 x 
105 (for 293T) cells were plated per 6 cm plate, containing 5 ml of media. The cells 
were allowed to settle for 4 to 12 hours before addition of the transfection mix. 
Therefore the appropriate DNA’s and 10 µg salmon sperm DNA as carrier were 
mixed together for each sample. 250 µl of a 250 mM CaCl2 solution were added 
and samples were mixed. Slowly 250 µl of either 2 x HBS pH 7.05 (280 mM NaCl; 
10 mM KCl; 1.5 mM Na2HPO4; 12 mM dextrose; 50 mM HEPES) or 2 x BES pH 
7.1 (50 mM N,N-bis[2-hydroxyethyl]-2-aminoethanesulfonic acid; 280 mM NaCl; 
1.5 mM Na2HPO4) were added drop by drop and the mixture was incubated for 30 
minutes at room temperature. The solution was added to the prepared plates and 
incubated between 8 and 20 hours depending on the cell type. Cells with low 
transfection efficiency were incubated using 2 x BES and the incubation was done 
at least over night in an incubator with 3% CO2. Following the incubation the cells 
were once washed with media, then 5 ml of fresh media were added. 36 to 48 
hours after the addition of the transfection mix the cells were harvested. 
 
 
3.5.2. Non-adherent cells 
 
Non adherent cells, mostly lymphoid cells, were transfected using electroporation. 
Per transfection 5 x 106 cells were diluted either into 500 µl medium for easier 
transfectable cells as Jurkat cells or into 250 µl medium for harder transfectable 
cells as Hut78 or primary cells. DNA was added to the cell suspension and the 
whole mixture was transferred into a Bio-Rad Gene Pulser Cuvette (0.4 cm 
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electrode). The cell suspension was shocked with 250V and 975F. Folowing the 
electro shock the cells were immediately transferred into a Falcon tube containing 
5ml of media and incubated one to two hours at 37°C. After this period of 
recreation the cells were centrifuged and resuspended in 10 ml fresh media. After 
36 to 48 hours the cells were harvested and analyzed. 
 
 
3.6. Luciferase assay 
 
Transfected cells were harvested after 36 to 48 hours and washed once with PBS 
without Ca2+ and Mg2+. The cell pellets were resuspended in 100 - 200 µl of 1 x 
Reporter Lysis buffer (proprietary formulation of bicine buffer and Tween 
detergents, Promega) or 1 x Passive Lysis buffer (Promega) for Dual Luciferase 
measurements. The cell suspensions were frozen in ethanol/dry ice and thawed at 
room temperature. The luciferase reagent (Luciferase Assay Substrate, Promega) 
and also the second component needed for Dual Luciferase measurements, Stop 
& Glo Reagent (Promega) were thawed at room temperature and 20 µl of the 
lysates were measured in the “Luminat LB 9507”. 
The values were normalized for transfection efficiency either using β-
galactosidase, chloramphenicol acetyltransferase (CAT), or Renilla Luciferase 
measured in parallel with the firefly Luciferase. 
 
 
3.7. β-gal assay 
 
The co-transfected β-galactosidase was measured using chlorphenolred- β-D 
galactopyranosid (CPRG). Therefore 20 µl of the cell lysates were mixed with 180 
µl of a mixture of 10 ml Z buffer (60 mM Na2HPO4; 40 mM NaH2PO4; 10 mM KCl; 
10 mM MgSO4), 100 µl 50 mM CPRG, and 10 µl β-mercaptoethanol. The release 
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of chlorphenolred by the β−galactosidase was monitored in a 96-well plate using 
the Spectra Max 250 of Molecular Devices. 
 
 
3.8. CAT assay 
 
The chloramphenicol acetyltransferase (CAT) assay was carried out with 14C 
labeled acetyl coenzym A (acetyl CoA). 20 µl of the CAT reaction mixture  
 
Reagent Volume 
14C acetyl CoA 3 µl 
20 mM acetyl CoA 0.1 µl 
0.25 M Tris-Cl, pH 7.4 5 µl 
8 mM Chloramphenicol 10 µl 
H2O 1.9 µl 
Final Volume 20 µl 
 
were added to 30 µl of transfection lysates. The reaction was incubated for 4 hours 
at 37°C, then 210 µl of ethylacetate were added and the aqueous phase extracted 
by mixing. The samples were centrifuged at room temperature at maximum speed 
for 4 minutes. 180 µl of the upper phase were transferred into 3 ml of scintillation 
fluid and counted for 14C activity. 
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3.9. Flow cytometry 
 
3.9.1. FACS sorting 
 
Cells were transfected with the appropriate constructs to look for endogenous 
gene regulations. GFP was either co-expressed from a bicistronic vector or co-
transfected with the other plasmids to detect which cells were transfected. 24 to 36 
hours after transfection, the cells were harvested and resuspended in cell 
dissociation solution (SIGMA). GFP positive cells were sorted either with a BD 
Facs sorter Advantage using the Cell Quest software or with a Cytomation MoFlo 
sorter using the Summit software. 
 
 
3.9.2. FACS analysis 
 
To identify different cell populations the cells were stained with antibodies 
conjugated to different dyes specific for the surface markers of interest. The colors 
used were fluorescein isothiocyanat (FITC), phycoerythrin (PE), allophycecyanin 
(APC), and propidium iodide to exclude dead cells. First the cells were harvested 
as described before, then washed twice with FACS buffer (3% FCS; 0.1% Sodium 
Azide; in PBS), and finally resuspended in an appropriate volume of this buffer. 
The cells were counted and 1x107 cells per sample were transferred to small 
FACS tubes. For blocking of unspecific binding the cells were incubated on ice for 
15 minutes in a 1:200 dilution of FcR (αCD16/CD32) block in FACS buffer to target 
the Fc receptors on lymphoid cells, which in non-blocked state unspecifically bind 
the antibodies employed for FACS analysis. Following the cells were incubated 
with the desired antibody in FACS buffer for 30 minutes on ice. Next the cells were 
washed three times with FACS buffer and finally they were resuspended in 250 µl 
of FACS buffer and ready for the analysis. 
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3.10. RNA preparation 
 
Total RNA was isolated form adherent or non-adherent cells. For adherent cells, 
the media of the culture plate was aspirated off, the plates were washed with PBS 
without Ca2+ and Mg2+ and 1 ml of TRIZOL (Invitrogen) was added. The 
TRIZOL/cell mixture was transferred to an Eppendorf tube. Non-adherent cells 
were centrifuged, the supernatant was aspirated off, and the cell pellet was 
washed with PBS without Ca2+ and Mg2+. TRIZOL was added and the cells were 
transferred to an Eppendorf tube. The tubes were frozen at -80°C for storage or for 
further preparation of the RNA. After thawing the TRIZOL/cell mixture the genomic 
DNA was destroyed by shearing it through a syringe ten times. 200 µl of 
chloroform were added and vortexed for mixing. After 5 minutes at room 
temperature phase separation was achieved by centrifugation for 20 minutes at 
4°C at maximal speed. The upper phase was transferred to a new tube, avoiding 
touching the interphase. 500 µl of isopropanol were added followed by a 10 
minutes incubation phase at room temperature. Then the samples were 
centrifuged at maximal speed for 10 minutes at 4°C. The supernatant was 
aspirated off and the pellet was washed with 70% ethanol. Finally the pellet was 
resuspended in an adequate volume of  
diethylpyrocarbonate (DEPC) treated water. 
 
 
 
 
3.11. Reverse transcription 
 
RNA was transcribed to cDNA serving as a template for PCR reactions. Therefore 
the following reaction was set up: 
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Reagent Volume 
Total RNA (5µg)   x µl 
H2O   y µl 
Oligo d(t15) primer   2 µl 
Final volume 10.6 µl 
 
The samples were heated up to 70°C for 10 minutes, then kept on ice for two 
minutes and supplemented with: 
 
Reagents Volume 
First strand buffer   4 µl 
Dithiothreitol (DTT)   2 µl 
dNTP (25 mM each)   0.4 µl 
RNAsin (Sigma)   1 µl 
Superscript II, Reverse Transcriptase 
(Invitrogen 200U/µ) 
  2 µl  
Final Volume 20 µl 
 
As negative control, one reaction was prepared without Superscript II. The 
reactions were incubated at 37°C for one hour. The volume was adjusted to 40 µl 
with water and 0.5 µl were used for one PCR reaction. 
 
 
3.12. Northern blot hybridization 
 
3.12.1. Formaldehyde agarose gel electrophoresis 
 
For visualization of RNA in agarose gels, ethidium bromide was added directly to 
the samples to avoid high background fluorescence. A volume corresponding to 3 
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µg poly-A+ RNA or 15 µg total RNA was withdrawn and DEPC treated H2O was 
added to 20 µl final volume. Then 20 µl of a formaldehyde/formamide mix were 
added to the RNA: 
 
Reagents Volume 
Formamide 100 µl 
Formaldehyde   20 µl 
10x MOPS (0.2 M MOPS, pH 7.0; 5 mM 
EDTA, pH 8.0; 40 mM Sodium Acetate, pH 
7.0) 
  20 µl 
Fthidium bromide (10 mg/ml)     1 µl 
H2O     9 µl 
Final Volume 150 µl 
 
The samples were incubated at 65°C for 10 minutes, then cooled on ice for 10 
minutes. The samples were separated on a 1 x MOPS gel containing 1% agarose 
and the gel was run at 140 V. The RNA was visualized and the gel photographed 
with a gel documentation system (IS-100 from Alpha Innotech Corporation). The 
location of the 28S (corresponding to 4718 nucleotides) and 18S (corresponding to 
1874 nucleotides) rRNA molecules were marked in the gel with a Pasteur pipette. 
 
 
3.12.2. Transfer of RNA to nitrocellulose membrane 
 
3 pieces of Whatman 3MM paper and one piece of Hybond-N+ nitrocellulose 
membrane (Amersham) were cut in the size of the gel. The Whatman papers and 
the gel were presoaked in 20 x NaCl/sodium citrate (SSC) (3 M NaCl; 0.3 M 
sodium citrate; adjusted to pH 7.0). A stack of paper towels was arranged as a 
sponge on the bench, on top three Whatman papers, the membrane, and last the 
gel topside facing up, were added. A saran wrap enclosed the whole transfer to 
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avoid evaporation of the buffer. On top of the stack a heavy book was placed for 
compression.  
 
        Heavy book 
 
        Agarose gel 
        Nitrocellulose membrane 
        Presoaked Whatman paper 
        
        Paper towels 
 
        Saran wrap 
 
The RNA was transferred to the nitrocellulose membrane over night. To immobilize 
the RNA, the membrane was UV-crosslinked in a transilluminator (Spectronics 
Corporation) 
 
 
3.12.3. Preparation of the probe 
 
The probes were prepared with the Rediprime II random labeling system kit 
(Amersham), which takes advantage of random sequence hexanucleotides to 
prime DNA synthesis at numerous sites along the denatured template DNA. 25 ng 
of linearized template in 45 µl of TE-buffer were denatured by boiling for 5 minutes 
at 100°C. The solution was cooled on ice, collected by centrifugation, and added 
to the Rediprime reaction tube. 5 µl of Redivue [α-32P]-dCTP (3000 mCi) were 
added to the reaction mix and incubated for 30 minutes at 37°C. 50 µl H2O was 
added to increase the volume. To remove free nucleotides, the probe mixture was 
loaded on a pre-spun (1100 x g for 2 minutes) Quick Spin Column (Roche) and 
centrifuged at 1100 x g for 4 minutes to collect the purified probe in a fresh 
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Eppendorf tube. 1 µl of the probe was used for counting the activity in a 
scintillation counter. 
 
 
3.12.4. Hybridization 
 
The nitrocellulose membrane was placed in a hybridization tube with the RNA-side 
facing the center of the tube. For hybridization a mix without formamide was used 
(50 mM NaxPO4, pH 7.0; 1% (w/v) SDS; 1 x Denhardt’s; 5 x SSC; 1 mg/ml yeast t-
RNA). The membrane was first pre-hybridized for 1-2 hours in 20 ml of the 
hybridization mix at 68°C. The probe was added to the tube in a volume 
corresponding to an activity of 750000 cpm/ml. The hybridization was carried out 
at 68°C over night. 
The next morning the hybridization mix was poured off and the nitrocellulose 
membrane was washed in the tube once with 5 x SSC for 10 minutes at 68°C, 
twice with 2 x SSC; 0.5% (w/v) SDS for 15 minutes at 68°C. 
The wetted nitrocellulose membrane was wrapped in foil and autoradiography 
films (Kodak) were exposed to it in a cassette at -80°C.  
For reprobing, the membrane was stripped by boiling in hot 40 mM Tris-Cl, pH 7.5; 
1% (w/v) SDS) for 10 minutes. 
 
 
3.13. Affymetrix chip  
 
3.13.1. Preparation and labeling of the RNA 
3.13.1.1. Standard procedure 
 
Total RNA was prepared as described previously. For a standard procedure 
between 30 and 50 µg of total RNA were used as starting material. RNA was first 
transcribed to single stranded (ss) cDNA. 
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Reagents Volume 
Total RNA (5 – 50 µg) x µl 
DEPC- treated H2O y µl 
T7-(dT)24 primer (100 pmol/µl) 1 µl 
Final volume 11 µl 
 
The reactions were incubated at 70°C for 10 minutes. Then 5 x First strand buffer ( 
250 mM Tris-Cl, pH 8.3; 375 mM KCl; 15 mM MgCl2), 0.1 M DTT, and 10 mM 
dNTP mix were added. 
 
 
Reagents Volume 
5x First strand buffer 4 µl 
DTT (0.1 M) 2 µl 
dNTP mix (10 mM) 1 µl 
Final Volume 18 µl 
 
The samples were heated to 37°C for two minutes. Finally the reverse 
transcriptase Superscript II was added. 
 
 
Reagents Volume 
Superscript II (200 U/µl) 2 µl 
Final Volume 20 µl 
 
The reaction was incubated at 42°C for one hour. The First Strand reaction was 
placed on ice and the reagents listed below in the  Second Strand final reaction 
composition table were added. 
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Reagents Volume 
DEPC treated H2O 91 µl 
5 x Second strand buffer (Invitrogen) 30 µl 
DNA Polymerase I (Invitrogen, 40 U/µl) 4 µl 
dNTP mix (10 mM each) 3 µl 
DNA ligase (Invitrogen, 10 U/µl) 1 µl 
RNAse H (Invitrogen, 2 U/µl) 1 µl 
Final Volume 150 µl 
 
The samples were incubated at 16c for two hours. The reaction were purified by 
performing one phenol/chloroform and one chloroform extraction, followed by an 
ethanol precipitation. Finally the pellet was washed with 80% ethanol and air dried 
before resuspending in 24 µl DEPC treated H2O. 
The last reaction step was an in vitro transcription of the ds cDNA into RNA, 
thereby using biotinylated dNTP’s to incorporate biotin into the produced RNA. For 
this purpose the labeling kit RNA Transcript Labeling Kit supplied by Enzo 
BioArray was used. 
 
Reagents  Volume 
Template ds DNA 24 µl 
10 x HY reaction buffer 4 µl 
10 x Biotin Labeled Ribonucleotides 4 µl 
10 x DTT 4 µl 
10 x RNAse Inhibitor mix 4µl 
20 x T7 RNA Polymerase 2 µl 
Total Volume 40 µl 
 
The tube was immediately incubated for 4 hours at 37v, mixing the contents every 
30 - 45 minutes. The reaction was cleaned by using the RNeasy Mini Kit supplied 
by Quiagen. The amount of labeled RNA was quantitated by spectrophotometry.  
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3.13.1.2. Preparation for low RNA amounts 
 
When the starting material was limited, the RNA had to be amplified. Therefore the 
procedure was accomplished as described, preparing ds cDNA. Then the in vitro 
transcription (IVT) was carried out with normal not biotinylated nucleotides, using 
the AmbionTM T7 Megascript Kit. 
 
Reagents Volume 
DEPC treated H2O y µl 
dATP 4 µl 
dCTP 4 µl 
dGTP 4 µl 
dUTTP 4 µl 
10 x buffer (Ambion, T7 Megascript) 4 µl 
Enzyme Mix 4 µl 
DNA x µl 
Total Volume 40 µl 
 
The IVT was followed by a second and third round of ds cDNA amplification. The 
third IVT was carried out using the EnzoTM Kit with its biotinylated nucleotides as 
described before. 
3.13.2. Fragmentation of the RNA 
 
16 µg of labeled RNA were fragmented to obtain pieces mainly between 100 and 
500 basepairs. This was achieved by adding a 5 x Fragmentation buffer (200 mM 
Tris-acetate, pH 8.1; 500 mM potassiumacetate, 150 mM magnesiumacetate) to a 
final concentration of 1 x and incubation of the sample at 94°C for 35 minutes.  
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3.13.3. Hybridization of the microarray 
 
The components for the hybridization were added to the fragmented RNA. 
 
Reagents Volume 
RNA 30 µl 
Control oligo B2 (oligo for the antisense 
probe array) 
5 µl 
20 x Eukaryotic Mix (eukaryotic control 
oligos for hybridization quality check) 
15 µl 
Hering sperm DNA 3 µl 
Acetylated Bovine Serum Albumin (BSA) 3 µl 
2 x Hybridization buffer ( 200 mM MES; 2 M 
[Na+]; 40 mM EDTA; 0.01% Tween 20) 
150 µl 
H2O 94 µl 
Final volume 300 µl 
 
The contents were heated at 95°C for 5 minutes and then centrifuged at maximal 
speed at room temperature for 5 minutes. The Affymetrix Chip was calibrated by 
filling it with 1 x MES buffer (0.1 M MES; 0.07 M [Na+]) through one of the septa 
and incubated at 45°C for 10 minutes under rotation. Then the buffer solution was 
removed and the array was filled with the clarified hybridization cocktail avoiding 
any insoluble material at the bottom of the tube. Finally the probe array was placed 
in a rotisserie box in a 45°C oven and hybridized for 16 hours.  
 
 
3.13.4. Washing, Staining, and Scanning of the microarrays 
 
After 16 hours of hybridization, the hybridization cocktail was removed from the 
probe array and set aside in a microcentrifuge tube. The probe array was 
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completely filled with non-stringent wash buffer (0.9 M NaCl; 6 mM EDTA; 0.01% 
Tween 20; 0.005% Antifoam), called buffer A. The Affymetrix Fluidics Station was 
prepared and the protocol for the chip chosen. The Streptavidin Phycoerythrin 
(SAPE) staining solution was prepared: 
 
Reagents Volume 
2 x Stain buffer (200 mM MES; 2 M [Na+]; 
0.05% Tween 20; 0.005% Antifoam) 
600 µl 
Acetylated BSA (50 mg/ml) 48 µl 
Streptavidin Phycoerythrin (SAPE) (1 mg/ml) 12 µl 
H2O 540 µl 
Final Volume 600 µl 
 
At the same time the antibody solution was prepared. 
 
 
Reagents Volume 
2 x Stain buffer 300 µl 
Acetylated BSA (50 mg/ml) 24 µl 
Normal goat IgG (10 mg/ml) 6.0 µl 
Biotinylated antibody (0.5 mg/ml) 3.6 µl 
H2O  266,4 µl 
Final Volume 600 µl 
 
The microarray was inserted into the Fluidics Station and the program started that 
controls the staining and washing procedure independently. The procedure 
comprised several washings with buffer A and the more stringent buffer B (100 
mM MES; 0.1 M [Na+]; 0.01% Tween 20). Next, the chip was incubated with the 
SAPE solution for several minutes. The probe array was washed again followed by 
the addition of the antibody solution. Before adding the SAPE solution for the 
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second time, the array was washed the same way. Following the final washing 
cycle, the chip was put for scanning.  
 
 
3.14. Preparation of total protein extracts 
 
Plates of adherent cells were washed twice with PBS without Ca2+ and Mg2+ and 
kept on ice during further preparation steps. The cells were lysed in an appropriate 
volume of RIPA buffer (10mM NaxPO4, pH 7.2; 150 mM NaCl; 1% (v/v) Triton X-
100; 1% (w/v) Sodium Deoxycholate; 0.1% (w/v) SDS; 1 mM DTT) with 1 x 
protease inhibitor mix (pim) (5 µg/ml Soybean Trypsin/Chymotrypsin inhibitor; 5 
µg/ml Antipain; 5 µg/ml Aprotinin; 5 µg/ml Leupeptin; 0.5 µg/ml Pepstatin A; 5 
µg/ml Bestain in 20 mM Tris-Cl, pH 7.9), and 1 mM phenylmethylsulfonyl fluoride 
(PMSF) added just before harvesting. After 5 minutes of incubation the cells were 
scraped off with a rubber policeman and transferred to a new Eppendorf tube. 
Suspension cells were shaken from the walls of the culture flasks and the culture 
suspension was transferred to a Falcon tube. The cells were spun down, washed 
twice in PBS without Ca2+ and Mg2+, and transferred to Eppendorf tubes, which 
were kept on ice during subsequent preparation. Following a short centrifugation 
step, the supernatant was aspirated off and the pellet was resuspended in 5 times 
the volume of the pellet of RIPA buffer including 1 x pim and 1 mM PMSF. If 
necessary the sample was sonicated to destroy the genomic DNA. After 
centrifugation for 2 minutes at maximal speed at 4°C, the supernatant containing 
the total protein extract was transferred to a new Eppendorf tube and the 
concentration of protein was determined by Bradford assay. The total protein 
extract was stored at –80°C. 
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3.15. Western blot analysis 
 
3.15.1. Gel electrophoresis and transfer to nitrocellulose filter 
 
A protein gel was made up of a stacking gel (3.9% acrylamide; 0.104% 
bisacrylamide; 0.125 M Tris-Cl, pH 6.8; 0.1% (w/v) SDS; 0.15% (w/v) ammonium 
persulfate; 0.2% TEMED) and a separating gel with the appropriate 
acrylamide/bisacrylamide content. For analysis of LEF-1, a protein running at 
approximately 60 kDa, a 10% acrylamide gel was used (10% acrylamide; 0.24% 
bisacrylamide; 0.375 M Tris-Cl, pH 8.8; 0.1% (w/v) ammonium persulfate; 0.13% 
TEMED). 
The protein samples were filled up with H2O to 40 µl and 10 µl of sample buffer 
(100 mM Tris-Cl, pH 6.8; 200 mM DTT; 4% SDS; 2% bromphenolblue; 20% 
glycerol) were added. The samples were boiled at 95°C for 4 minutes and 
centrifuged shortly to bring contents down to the bottom. Then they were loaded 
on the gel together with a broad range prestained protein marker (BioRad). The 
gel was run in 1 x Tris-glycine buffer (1.25 M glycine, 125 mM Tris-Cl; 0.5% (w/v) 
SDS) at 20 mA through the stacking gel and at 40 mA through the separating gel.  
The transfer of separated proteins from the gel to a piece of nitrocellulose transfer 
membrane (Schleicher and Schuell) was carefully set up under transfer buffer 
(20% methanol in 1x Tris-glycine buffer) to avoid air pockets. The transfer was run 
in a cold room at 60 V for two hours or at 20 V overnight.  
 
 
3.15.2. Immunodetection 
 
To block non-specific binding, the nitrocellulose filter was incubated in 5% (w/v) 
non- fat dry milk in 1 x PBS-T (137 mM NaCl; 2.7 mM KCl; 4.3 mM Na2HPO4; 1.4 
mM KH2PO4, pH 7.4 with 0.1% Tween 20) or in 5% (w/v) BSA in 1 x PBS-T for one 
hour at room temperature or overnight in the cold room on a rocking plate. The blot 
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was washed once for 15 minutes and twice for 10 minutes in PBS-T. A primary 
antibody recognizing the protein of interest was diluted in PBS-T to the optimized 
concentration. The blot was incubated in the antibody solution for one hour at 
room temperature with agitation and washed once for 15 minutes and twice for 10 
minutes in PBS-T. A horseradish peroxides (HRP)-labeled secondary antibody 
specific for the utilized primary antibody was diluted in PBS-T and the blot was 
incubated in the solution for one hour at room temperature with agitation. For 
immunoblotting the following antibody concentrations were used: 
 
Primary antibody Dilution Sec. antibody Dilution 
Rabbit αmouse LEF-1 1:4000 αrabbit-HRP 1:10000 
Rabbit αmouse SATB1 1:2500 αrabbit-HRP 1:10000 
Goat αmouse LaminB 1:1000 αgoat-HRP 1:3000 
 
The nitrocellulose filter was washed once for 15 minutes and twice for 10 minutes 
in PBS-T and the liquid was drained off on a piece of Kim Wipes. 
Immunodetection was performed with ECL Western blotting analysis system 
(Amersham). 3 ml of reagent 1 and 3 ml of reagent 2 were added to the protein 
side of the membrane and incubated for one minute at room temperature. The 
filter was wicked dry on a piece of Kim Wipes and it was carefully wrapped in 
Saran Wrap carefully avoiding air bubbles. Auto radiography film were exposed to 
the membrane for appropriate time periods.  
If the membrane was to be reprobed, primary and secondary antibodies were 
stripped off by incubating it in stripping buffer (100 mM β-mercaptoethanol; 2% 
(w/v) SDS; 62.5 mM Tris-Cl, pH 6.7) at 65°C for 30 minutes. The membrane was 
washed twice in PBS-T for 10 minutes and blocked for one hour at room 
temperature in 5% non-fat dry milk before performing immunodetection. 
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3.16. Bacteria cultures 
 
Escherichia coli (E. coli) strains were grown up by culturing them in liquid Luria 
Bertani (LB) media (1% tryptone; 0.5% yeast extract; 1% NaCl) at 37°C with 
agitation or plating them out on LB plates (LB media with 1.5% agar), which where 
incubated at 37°C. 
For storage, bacteria cultures were quick-frozen in liquid nitrogen and stored at -
80°C in LB media containing 25% glycerol. To recover the bacteria, the top of the 
frozen sample was scraped with an inoculation loop and the bacteria were plated 
onto a media plate, which was incubated overnight at 37°C. 
 
 
3.17. Mini preps 
 
To check if a cloning step worked, small amounts of DNA were prepared, so called 
Mini preps. DNA was prepared using the boil-lysis method. 1.5 ml of an over night 
culture were centrifuged at full speed for 5 minutes. The supernatant was 
discarded and the pellet resuspended in 200 µl of STET buffer (0.08% (w/v) 
sucrose; 0.05% (v/v) Triton X-100; 5 mM Tris-Cl, pH 8.0; 5 mM EDTA, pH 8.0) and 
10 µl Lysozym/Rnase mix (Lysozym 10 mg/ml; RNase 1 mg/ml; 5 mM EDTA, pH 
8.0). The samples were boiled at 95°C for 10 minutes. The suspension was 
centrifuged at maximal speed and the supernatant was transferred into a new 
Eppendorf tube. For precipitation 200 µl 5 M ammoniumacetat and 400 µl 
isopropanol were added and the samples were centrifuged at full speed for 15 
minutes in a cold centrifuge. The DNA pellet was washed with 70% ethanol, dried 
at 37°C, and resuspended in 30 µl of H2O. 5 µl were used for restriction digest 
analysis. 
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3.18. Maxi preps 
 
If larger amounts of DNA were needed, DNA was prepared in a large scale, so 
called Maxi preps. An 800 ml culture was inoculated and grown over night. The 
saturated culture was transferred to centrifuge bottles and centrifuged at 4000 rpm 
at 4°C for 15 minutes. The supernatant was discarded and the pellet dissolved in 6 
ml of solution I (5 mM glucose; 2.5 mM Tris-Cl, pH 8.0; 1 mM EDTA, pH 8.0). Then 
12 ml of solution II (20 mM NaOH; 1% SDS) were added and the samples 
incubated for 5 minutes on ice. Then 10 ml of solution III (3 M potassium acetate; 
11.5% glacial acetic acid) were added and placed on ice again for 5 minutes. The 
tubes were centrifuged in a Sorvall SS34 rotor for 15 minutes at 12000 rpm and 
the supernatant was filtered into a 50 ml Falcon tube. Isopropanol was added to 
the 50 ml mark, the tube was inverted several times and was incubated for 30 
minutes at room temperature. The precipitate was collected by centrifugation in a 
Rotanta Hettich swinging bucket centrifuge at 4000 rpm for 15 minutes at 4°C. The 
supernatant was discarded and the pellet dissolved in 3 ml of H2O. 5.0 g cesium 
chloride were dissolved and 100 µl ethidium bromide (10 mg/ml) added and the 
solution transferred into an ultracentrifuge quick seal tube. The tube was sealed 
and put into a VTI 65.2 rotor where it was run in an ultracentirfuge at 65000 rpm 
for at least 3.5 hours at roomtemperature. The DNA band was pulled out with a 
syringe and the volume adjusted to 6 ml with H2O. N-butanol was added to the 12 
ml level and ethidium bromide extracted by shaiking. After phaseseparation the 
upper phase was aspirated off and the procedure was repeated until the pink color 
was completely removed, paying attention that the H2O level stayed above 5 ml. 
After the last extraction cold ethanol was added to the 15 ml mark. The samples 
were stored at -20 °C for 30 minutes to allow precipitation. The tubes were 
centrifuged in a Rotanta Hettich centrifuge at 4000 rpm for 15 minutes at 4°C. The 
supernatant was discarded and the pellet washed with 70% ethanol, dried, and 
finally resuspended in an appropriate volume of H2O. 
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3.19. Mutagenenesis 
 
3.19.1. Production of single stranded DNA 
 
The DNA of interest was transformed into the E.coli strain CJ236. The bacterial 
suspension was plated on a LB plate containing ampicillin (100 µg/ml). The plate 
was incubated over night at 37°C. The next day a single colony was picked and a 
50 ml culture of LB containing 70 µg/ml ampicillin inoculated. After inoculation 2 µl 
of VCSM13 helper phage ( 1 ml ≅ 2 x 107 pfu/ml) were added. The culture was 
grown for about 2-3 hours, then 70 µg/ml kanamycin were added, and the culture 
was vigourously agitated over night. 40 ml of the infected cultures were centrifuged 
at 10000 rpm in a Sorvall SS34 fixed angel rotor. The supernatant was transferred 
to another centrifuge tube and spun again for another 10 minutes at 10000 rpm to 
ensure that no bacterial cells were present. The supernatant was transferred to a 
50 ml Falcon tube and 7 ml of 20% polyethylenglycol 8000 in 2.5 M NaCl were 
added and mixed by inverting the tube several times. The reaction was left at room 
temperature for 30 minutes. The precipitated bacteriophage particles were 
recovered by centrifugation at 4000 rpm for 20 minutes at 4°C in a Beckmann 
swinging bucket centrifuge. The supernatant was discarded and the pellet 
resuspended in 300 µl of TE (pH 8.0) and transferred to an Eppendorf tube. An 
equal volume of phenol was added and mixed vigorously. The sample was 
centrifuged at maximal speed for 2 minutes. The phenol extraction was repeated, 
followed by one phenol/chloroform (1:1 v/v) and one chloroform extraction. After 
the final extraction the supernatant was transferred to a new Eppendorf tube and 
2.5 volumes of 100% ethanol and 1/10th volume of 3 M sodium acetate, pH 5.0 
were added. The ssDNA was precipitated for 20 minutes at -80°C and centrifuged 
at 4°C for 20 minutes at full speed. The pellet was washed with 70% ethanol and 
the supernatant was discarded. The pellet was dried and resuspended in 20 µl of 
TE. 
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3.19.2. Oligo-nucleotide mediated site directed mutagenesis 
 
For the mutagenesis a primer was designed, that encoded the desired mutation in 
an antisense orientation to the origin of replication in the plasmid used. As a first 
step, the mutagenic primer was kinased. 
 
Reagent Volume 
Mutagenic primer (100 pmol/µl) 4 µl 
Kinase buffer (70 mM Tris-Cl, pH 7.6; 10 mM 
MgCl2; 5 mM DTT) 
2 µl 
ATP (10 mM) 1 µl 
T4 Polynucleotide Kinase (NEB) 1 µl 
H2O 9.5 µl 
Final Volume 16.5 µl 
  
The reaction was placed at 37°C for one hour, then stopped by heating to 65°C for 
15 minutes. The kinased primer were annealed with the single stranded DNA. 
 
Reagent Volume 
Single stranded DNA, 1 µg x µl 
Kinased mutagenic primer (10 pmol) 1 µl 
Reverse primer (1 pmol) 0.5 µl 
10 x PE1 buffer (200 mM Tris-Cl, pH 7.5; 
100 mM MgCl2; 500 mM NaCl; 10 mM DTT) 
1 µl 
H2O y µl 
Final Volume 10 µl 
 
For better transcription of the DNA template a second perfect match primer was 
added, also antisense to the origin of replication, referred to as reverse primer. If 
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two or more sites had to be mutated, this primer was exchanged with a second 
kinased mutagenic primer. Up to three kinased mutagenic primers were used 
successfully in one reaction to obtain a three point mutant. The reaction was put 
into a 95°C water bath and cooled slowly to room temperature. While the 
annealing reaction was cooling, the following mix was made up. 
 
Reagent Volume 
PE2 buffer (200 mM Tris-Cl, 7.5; 100 mM 
MgCl2; 100 mM DTT) 1 µl 
dNTP mix (10 mM each) 1 µl 
T4 DNA ligase (NEB)  1 µl 
Klenow (Roche, 2U/µl) 1 µl 
H2O 5 µl 
Final Volume 10 µl 
 
Once the annealing mixture had cooled to room temperature, the mix was added 
and the sample was incubated at 16°C over night. The next day 10 µl of the 
sample were transformed into DH5α. Between 10 and 20 colonies were analyzed 
for mutations. 
 
3.20. Electro mobility shift assay (EMSA) 
 
The DNA-binding assay using nondenaturing polyacrylamide gel electrophoresis 
(PAGE) provides a simple, rapid, and extremely sensitive method for detecting 
sequence-specific DNA-binding proteins. Proteins that bind specifically to an end-
labeled DNA fragment retard the mobility of the fragment during electrophoresis, 
resulting in discrete bands corresponding to the individual protein-DNA complexes. 
The assay can be used to test binding of purified proteins or of proteins found in 
crude extracts. 
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3.20.1. Probe preparation 
 
To generate the probe for an electro mobility shift assay (EMSA), oligos with the 
desired sequence were designed in sense and antisense direction. One of the 
oligos, or for stronger probes both oligos were endlabeled with γ-32P ATP. 
 
Reagents Volume 
Oligo (100 pmol/µl) 1 µl 
Polynucleotide Kinase buffer (NEB) 5 µl 
γ-32P ATP (6000 Ci/mmol) 5 µl 
T4 Polynucleotide Kinase (NEB) 2 µl 
H2O 37 µl 
Final Volume 50 µl 
 
The labeling reaction was precipitated by adding 2 µl of tRNA as carrier, 1/10 3 M 
Sodium acetate, pH 5.2, and 2.5 volumes of ethanol. The precipitate was 
resuspended in 4 µl of TE buffer. Next the annealing reaction was set up. 
 
Reagent Volume 
Labeled oligo sense (100pmol) 4 µl 
Labeled/unlabeled oligo antisense (100pmol) 4 µl 
NEB buffer 3 2 µl 
H2O 10 µl 
Final Volume 20 µl 
 
The sample was annealed in a thermo cycler: 85°C for 3 minutes; 65°C for 10 
minutes; 42°C for 15 minutes; 37°C for 10 minutes; 20°C for 5 minutes. Meanwhile 
a 20% gel, 2 mm thick, 25 cm long, was prepared with 1xTBE as buffer. It was pre 
run for 30 minutes at 500 V. The annealed probe was loaded on the gel and 
separated for 4-5 hours at 500 V. An autoradiography film was exposed to 
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visualize the labeled and annealed probe and the double stranded oligo was cut 
out. The slice of gel was crushed into small pieces and eluted over night with 450 
µl of elution buffer (0.5 M ammonium acetate; 10 mM magnesium acetate; 1 mM 
EDTA, pH 8.0; 0.1% SDS). The supernatant was transferred to a column to hold 
back small acrylamide pieces. At the end the sample was precipitated, washed 
with 70% ethanol, and resuspended in 20 µl of TE buffer. 
 
 
3.20.2. Gel preparation 
 
For the assay a 2 mm thick, 4% native acrylamide gel was prepared. The buffer 
was either 0.25 x TBE or 1 x Tris glycine (25 mM Tris-Cl, pH 8.3; 190 mM glycine; 
1 mM EDTA). The gel was prerun for 30 minutes at 150V before the samples were 
loaded. 
 
 
3.20.3. Band shift 
While the gel was prerunning, the binding reaction was assembled by combining 
the protein (10-500 ng recombinant protein, 0.5-2 µl) and 18 µl band shift buffer 
(75 mM NaCl; 20 mM Hepes pH 7.6; 10% glycerol; 2 mM DTT; 0.1 mg/ml BSA; 2 
µg/ml dI/dC). The total protein concentration was kept constant with additional 
BSA to obtain the same protein concentration in each sample. For supershifts a 
second protein or an antibody was added and the reaction incubated for 15 
minutes. The probe was diluted to 10000-20000 cpm/µl and 1 µl of it was added to 
the protein/buffer mix. The samples were incubated for 30 minutes and then 
loaded on the gel. After one hour the gel was put for drying and was exposed to an 
autoradiography film (Kodak). 
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4. Results 
 
4.1. NIH3T3 Fibroblasts 
  
4.1.1. Stable transfection of the inducible β-catenin-LEF1 fusion 
(CatCLEF) in NIH3T3 cells 
 
In a first approach to identify LEF-1 target genes in different regulatory processes, 
we were investigating the role of LEF-1 in a cell culture system. Therefore we 
decided to search for LEF-1 target genes in NIH3T3 cells, a murine fibroblastic cell 
line without endogenous LEF-1 expression, what gave us the possibility to express 
LEF-1 through transfection under controlled conditions. We mainly looked for 
genes regulated within the canonical Wnt pathway, thus regulated through the 
interaction of LEF-1 and β-catenin, so it was not enough to express LEF-1 alone. 
Overexpression of LEF-1 without β-catenin would most likely result in regulatory 
processes occurring without the help of β-catenin. Therefore, we were expressing 
a fusion of the C terminal part of β-catenin to LEF-1 (CatCLEF), which is a 
constitutive active form of LEF-1 (Figure 6A). This fusion ensures sufficient 
transcriptional activation as it was shown before (Hsu 1998) and will result in β-
catenin dependent and β-catenin independent target genes. To control the 
expression of CatCLEF and to look mainly at primary targets, the transfection was 
carried out with a two-step inducible system that allowed us to express CatCLEF 
only for a short period of time. We used the ecdysone-inducible mammalian 
expression system that consists of the two vectors pVgRXR and the pIND-based 
inducible expression vector. PVgRXR constitutively expresses the RXR and 
VgEcR receptor subunits that assemble to the ecdysone receptor. The pIND 
vector carried CatCLEF or was empty as control and could be selected with 
neomycin, while pVgRXR could be selected with zeocin. First one plasmid was 
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transfected and a stable clone selected, then the second plasmid was stably 
integrated. A clone stable for control (RXR) and CatCLEF (CatCLEF#29) was 
selected for further analysis. The stable cell lines were kindly provided by S.-C. 
Hsu. The clones were induced for 8 hours with 10 mM Ponasterone A and then 
harvested. An immunoblot analysis confirmed the induction of the CatCLEF#29 
clone but not of the RXR clone, showing that the system is completely shut off 
without estrogen addition (Figure 6B).  
 
 
4.1.2. Microarray analysis of induced NIH3T3 cells, carrying either 
CatCLEF or the empty plasmid 
 
4.1.2.1. Probe array hybridization 
 
CatCLEF#29 and RXR cells were compared using Affymetrix chip technology to 
find differentially regulated genes. Both cell lines were induced for 8 hours with 
Ponasterone A and then harvested. Total RNA was prepared and a standard 
labeling procedure was carried out according to Affymetrix protocols. The labeled 
cRNA was fragmented, mixed with the blocking reagents and standards and 
hybridized to the probe arrays Mu 6500 A, B, and C by S-C. Hsu. Mu 6500 arrays 
are mouse arrays, each spotted with 6500 oligo-nucleotides, so that the total 
analysis covered 19500 sequences. One third of them are known genes two thirds 
are sequences derived from EST’s. The chip was scanned, controlled, and 
subjected to analysis. We repeated that experiment using this time only one 
microarray MGU74Avs2 that contained 12000 spotted oligo-nucleotides on one 
array, some of them not spotted on the other type of chip. The microarrays are not 
completely comparable as for some genes the spotted sequence was changed 
what can result in a different strength of hybridization. 
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Figure 6. Induction control of the stable NIH3T3 cell lines. 
(A) Schematic diagram of LEF-1 and β-catenin and their fusion CatCLEF in which the
carboxyterminal (CatC) domain of β-catenin was linked to full length LEF-1. The β-catenin binding
domain (βBD), context-dependent activation domain (CAD), high-mobility-group domain (HMG), and
the armadillo repeats (Arm repeats) are indicated. 
(B) The control cell line (RXR) and the CatCLEF expressing cell line (CatCLEF#29) were tested for
their CatCLEF induction ability. Cells untreated and treated with Ponasterone A (8 hours, 10 mM)
were harvested and whole cell extract was prepared. The expression of LEF-1 was tested by
immunoblot analysis against LEF-1. Whole cell extract of PD36 cells was used as positive control.
Only induced CatCLEF#29 cells showed expression of CatCLEF without any leakiness in the
uninduced sample. B
A
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4.1.2.2. Analysis of the probe arrays 
 
Of each cell line three Mu 6500 A, B, and C probe arrays and one MGU74Avs2 
were hybridized. First the Mu 6500 chips were compared to each other, counting a 
gene as potential target if it was regulated at least in four out of the six 
comparisons (Figure 7B). Then we expanded the results with some new targets 
identified within the MGU74Avs2 screen and performed a cluster analysis for 
better visualization of the targets (Figure 7A). 
 
 A 
 
 
 
 
 
 
 
B 
 
Acc. # FC FC FC FC FC FC count av FC  
D16503 26.9 45.6 24.9 33 30.8 45.6 6 34.4 Lymphoid enhancer binding factor 1 
AA138226 13.5 19.1 6.3 10 10.6 15 6 12.5 Homologous to CLATHRIN LIGHT CHAIN B
U20497 11.1 5.5 8.3 4.1   4 7.3 Cdk4 and Cdk6 inhibitor p19 protein 
W59487 2.6 7.6 10.9 5.8   4 6.7 Homologous to ZINC FINGER PROTEIN 40 
X70058 5.1 6.2 4.1 11   4 6.5 Cytokine (fic)  
J04596 6.5 5.6 6.9 6   4 
6.3 
Platelet-derived growth factor-inducible KC 
protein  
AA071802 4.6 8  5.3  5.7 4 5.9 Homologous to APOPAIN PRECURSOR  
L24430 5.7 3.4 7.4 4.5   4 5.3 Osteocalcin precursor. bone gla protein 
W13586 6.6 4.1 5 3.7   4 
4.9 
Atrial/fetal isoform myosin alkali light chain 
(MALC)  
U05673  4.1  4.7 4.3 5.5 4 4.7 Adenosine receptor subtype  
U27267 4.4 4.1 3.7 3.5 3.2 3.1 6 3.7 LPS-induced C-X-C chemokine LIX 
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precursor 
X67469 3.3 4.1 3.2 4   4 3.7 AM2 receptor 
X03505 4.1 3.5 3.8 3.1   4 3.6 Serum amyloid A (SAA) 3 protein 
Msa.26.0  5.4 3.3 7.4 -4.2  4 
3.0 
Homologous to 
PHOSPHATIDYLINOSITOL-4-
PHOSPHATE 5-KINASE FAB1  
X83601 3.4 3 2.7 2.6   4 2.9 PTX3 mRNA 
M19681 3.1 2.9 3 2.7   4 
2.9 
Platelet-derived growth factor-inducible 
protein (JE) gene,  
U73004 2.7 2.7 2.9 2.9   4 2.8 Secretory leukocyte protease inhibitor 
U44725 2.4 2.3 2.4 2.4   4 2.4 Sl-d mutant allele kit ligand (KL)  
K03235   2.2 2.2 2.4 2.3 4 
2.3 
Mrp/plf3 gene for mitogen regulated 
protein/proliferin (MRP/PLF), exon 1  
X13171 -2.7 -2.4 -2.4 -2.2   4 -2.4 Histone H1(0) gene 
D76440 -2.4 -2.5 -2.2 -2.4 -3.4 -3.6 6 -2.8 Necdin 
AA068364 -3.4 -3.1 -3.2 -3.1   4 
-3.2 
Homologous to POSSIBLE DNA-REPAIR 
PROTEIN XP-E  
U72881 -3.4 -3.2 -3.9 -3.6   4 -3.5 RGS-r protein  
W45750  -4.2 -6.1 -8.2 2.9  4 
-3.9 
Homologous to GUANINE NUCLEOTIDE-
BINDING PROTEIN G(T)  
AA050644 -3.5 -3.6 -5 -5.1   4 
-4.3 
Homologous to MELANOMA-ASSOCIATED 
ANTIGEN XP  
W50866 -4.1 -4.8  -4.5  -3.9 4 
-4.3 
Homologous to CALCINEURIN B SUBUNIT 
ISOFORM 1 
W59687   -5 -6.1 -4 -6.1 4 
-5.3 
Homologous to ADENOSINE A2A 
RECEPTOR. 
M32484 -6.6 -8.6  -4.2 -4.2 -6.5 5 
-6.0 
Placenta and embryonic expression gene 
(pem)  
AA145547   -3.6 -5.1 -6.2 -9.9 4 
-6.2 
Homologous to LARGE PROLINE-RICH 
PROTEIN BAT2  
X75384  -4.9 -6.6 -8  -5.5 4 -6.3 Sax-1 gene encoded protein 
AA145487 -8.6 -5.5 -8.6 -6.3 -5.4  5 
-6.9 
Homologous to REPLICATION PROTEIN A 
70 KD DNA-BINDING SUBUNIT  
AA050551 -7.2 -8.3 -6.2 -6.8 -7.7 -8.5 6 
-7.5 
Homologous to CELL SURFACE 
GLYCOPROTEIN A15 (TALLA-1). 
D13266 -6.2 -7.7 -7.5 -8.7   4 -7.5 Glutamate receptor channel delta 2 subunit 
W83425 -8.3 -11 -6.3 -8.3  -5.5 5 -7.9 Homologous to Y BOX BINDING PROTEIN-
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1 (Y-BOX TRANSCRIPTIO 
AA117895 -10.5 -3 -8.5 -9.8 -8.1 -8.5 6 
-8.1 
Homologous to PROBABLE ATP-
DEPENDENT TRANSPORTER 
W08822 -10.1 -7.3 -9.4 -7.1   4 
-8.5 
Homologous to ZINC FINGER PROTEIN 
GLO3. 
 
 
 
 
 
Figure 7. Analysis of the chip screen of NIH3T3 cells. 
(A) Cluster analysis of the chip results; red for positive, green for negative regulation. 
(B) List of differentially regulated genes found on Mu 6500 probe arrays. Accession number
(Accession#), fold changes of the six comparisons (FC), regulation seen in how many comparisons
(count), average fold change (av FC), gene name or homology are indicated. 
 
 
4.1.3. Validation of targets with northern blot analysis 
 
For validation of the differentially regulated genes, the number of genes was cut 
down by choosing only the strongest regulated genes. Northern blot analysis was 
performed using RNA of induced CatCLEF#29 and RXR cells. For targets that 
were most likely to be expressed in pre-B cells, two additional cell lines were 
included. Pre-B cells isolated from fetal liver of wildtype mice (fl1) and of Lef1-/- 
mice (fl3) that have been infected with the Abelson virus for immortalization were 
added as a comparison for more natural conditions. The probes for the targets 
were synthesized by PCR, end-labeled with α 32P-dCTP and hybridized over night. 
Clathrin light chain, MAGE D2, pem, Glycoprotein A15, IGF-IIR, spi2, MCP-1 and 
two EST sequences could be validated (Figure 8). 
In table 1 the results of the chip screen were compared to the results of northern 
blot analysis. The fold changes detected with the microarrays are good 
reproducible with the northern blot analyses. 
Clathrin light chains are components of clathrin coated vesicles, structural 
constituents involved in endocytosis and membrane recycling (Broadsky 1988). In 
mammalian cells one form of clathrin heavy chain is known, but two classes  of  
light  chains,  light  chain  A  (LCA)  and light  chain  B  (LCB),  in contrast to 
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Figure 8. Northern blot analysis for validation of target genes of the NIH3T3 screen. 
Northern blot analysis was carried out with 15 µg of total RNA or 5 µg of mRNA of CatCLEF#29
and RXR cell lines induced for 8 hours with 10mM Ponasterone A, or of fetal liver derived,
Abelson infected pre-B cells of wildtype (fl1) and Lef1-/- (fl3) cells. PCR amplified and 32P-labeled
probes of the validated genes were hybridized to the RNA. The pre-B cell lines fl1 and fl3 are
included for some genes as controls. We could validate clathrin light chain, MAGE D2, pem,
Glycoprotein A15, IGF-IIR, spi2, MCP-1, and two ESTs without close homologies.  
 
Gene name FC Mu 6500 FC MG U 74A 
vs2 
FC Northern 
blot 
Clathrin light chain 12.5 1.6 5 
EST for zinc finger protein 6.7 n.d. 2.1 
Mage D2 -4.3 -2.2 -3.4 
EST -5.7 n.d. -5.7 
Glycoprotein A15 -7.5 -2.7 -7.5 
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Insulin like growth factor receptor 
(IGF-IIR) 
n.d. -7.9 -7.7 
Small inducible cytokine (MCP-1) n.d. -9.3 -5.7 
Pem -6.0 -20 -15.7 
Spi2 proteinase inhibitor n.d. -15.6 -19.4 
 
 Table 1. Comparison of the results detected with the microarray analysis and the northern blotanalysis.  
 
the single light chain of yeast (Payne 1985; Jackson 1987; Kirchhausen 1987; 
Jackson 1988; Silveira 1990). The EST found 
to be regulated was homologue to the human LCB form. The precise role of the 
Clathrin light chains is uncertain. In vitro evidence that they bind calmodulin (Pley 
1995) and are essential for the activity of an uncoating ATPase (DeLuca-Flaherty 
1990) points to them being regulatory elements in Clathrin function. Neither is the 
purpose of the light chain polymorphism established. LCB is specifically 
phosphorylated both in vitro (Bar-Zvi 1986) and in vivo (Cantournet 1987) by a 
casein-kinase II-like activity.  
Glycoprotein A15 is a member of the transmembrane 4 superfamily (TM4SF), 
also known as the tetraspanin that is characterized by four transmembrane 
domains. The TM4SF family comprises more than 20 known genes (Hotta 1988; 
Classon 1989; Amiot 1990). A15 is most abundantly expressed in brain but can 
also be detected in heart, lung, kidney, colon, and muscle (Hosokawa 1999). The 
function of A15 and its family members is largely unknown, but it is likely that they 
are involved in diverse processes such as cell activation and proliferation, 
adhesion and motility, differentiation, and cancer. 
The serine proteinase inhibitor 2 (spi2) is a protein subfamily that belongs to a 
superfamily including active serine proteinase inhibitors, as well as proteins with 
other biological roles but no known inhibitory activity. The proteins are involved in 
the control of proteinases central to the coagulation cascade, fibrinolysis, the 
complement cascade, and the acute phase response (Travis 1983; Carell 1987).  
The melanoma antigen-encoding gene (MAGE) D2 belongs to the MAGE family. 
Those family members are expressed in a variety of tumors but not in normal cells, 
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with the exception of the male germ cell, placenta, and, possibly cells of the 
developing embryo (Clotman 2000; Osterlund 2000). MAGE-D genes are 
particularly well conserved between man and mouse, suggesting that they exert an 
important function (Chomez 2001), although the cellular function of this protein 
family remains still unknown. 
The small inducible cytokine A2 encodes the monocyte specific chemotactic factor 
MCP-1. MCP-1 is thought to play an important role in monocyte infiltration in the 
immune response (Yoshimura 1989; Leonard 1990) and is a monocyte specific 
chemotactic factor that belongs to the newly identified cytokine superfamily, 
intercrine/chemokine (Oppenheim 1991; Schall 1991). It is produced by a variety 
of cell types, including monocytes, fibroblasts, vascular endothelial cells, and 
smooth muscle cells in response to various stimuli such as lipopolysaccherid 
(LPS), interleukin-1 (IL-1), tumor necrosis factor (TNF), plateled-derived growth 
factor, Interferon-γ (IFN-γ), and TPA (Rollins 1991; Colotta 1992).  
The placenta and embryonic expression early gene (pem) is an oncofetal gene 
expressed in a stage-specific manner during murine embryonic development. Pem 
is highly expressed in T-lymphoma cell clones and not detectable in normal 
lymphoid tissue (Mac Leod 1990). It is abundantly expressed in immortalized and 
malignant cells from different cell lineages, including epithelial cell lines, but is not 
detectable in differentiated adult tissues (Mac Leod 1990; Wilkinson 1990). Pem 
encodes a protein containing a homeodomain (Sasaki 1991). The homeobox motif 
is a 60 amino acid segment that encodes a helix-turn-helix (HTH) domain, which 
binds DNA and has structural similarities with prokaryotic HTH transcriptions 
factors (reviewed by (Scott 1989)). Pem has greatest homologies with the paired 
(prd) family, also encoding a homeodomain. In mammals, the known members are 
the murine S8 (Kongsuwan 1988), and the murine Pax 3, 6, and 7 genes (Kessel 
1990). We found pem to be expressed in the stable cell line RXR as it is described 
for immortalized cell lines. Expression of LEF-1 resulted in a drastic down 
regulation within 8 hours to undetectable levels, making it a potent candidate for 
direct regulation.  
The insulin-like growth factor II receptor (IGF-IIR) is a multifunctional membrane-
spanning glycoprotein that interacts with diverse proteins bearing a mannose 6-
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phosphate (M6P) recognition signal and with the nonglycosylated growth factor 
IGF-II (Kornfeld 1992). Biochemical studies have demonstrated that the receptor is 
responsible for targeting lyosomal enzymes from their sites of synthesis in the 
Golgi to an acidic prelysosomal compartment. About the regulation of IGF-IIR not 
much is known so far, but it could be shown that the promoter has two E-boxes, 
potential binding sites for helix-loop-helix proteins (Faisst 1992), and a binding site 
for the transcriptional activator SP1 (Liu 1995). As a helix-loop-helix leucine-zipper 
protein, c-myc can bind the identified E-box sequence. C-myc is broadly 
expressed during embryogenesis and in tissue compartments of the adult that 
possess high proliferative capacity such as skin. As The IGF-IIR receptor was 
shown to have the potential to be bound by c-myc and c-myc is a known target of 
the Wnt pathway and was identified to be regulated through its LEF/TCF binding 
sites (He 1998), we decided to further analyze the IGF-IIR gene.  
 
 
4.1.4. IGF-IIR promoter 
 
4.1.4.1. Cloning of the IGF-IIR promoter 
 
To study whether the IGF-IIR is a direct target of LEF-1, we analyzed its promoter 
for LEF-1 responsiveness. The promoter has already been identified (Liu 1995) 
and so we were searching within the sequence for potential LEF-1 binding sites. 
One strong consensus and two weaker binding sites compared to the perfect 
TCRα site could be identified. The whole promoter was cloned upstream of the 
firefly luciferase together with two truncated promoter constructs (Figure 9). The 
truncations had either only two LEF-1 binding sites (IGF-IIR-2), or only one 
residual LEF-1 consensus motif (IGF-IIR-1).  
 
 
 
 
Results   58 
 
 
 A  
-716  ccgccttat gtaatatgga tgctgcatat tatctttaca gaataataaa 
–667 actttgtaac agaggtggtg gtacacgctt ctaaacctag aactcggtag 
–617 gcttaagtag agggatctga actccagtat agcctgagct acatagtaag 
              • 
–567 caatctcacg ctaaaagttt ttttttgttt gtcatttgct tgttacattt 
–517 tggtttctct gcacactgca tattagtcca ccagtcacct aacttgctgt 
     ∗ 
–467 agaaagccct gcttgggaag tcacatttcc acagagctgc tgtgaggctc 
–417 tccggggcat gagtcggaaa ctcccacgcg ggattctaga aagactgacc 
–367 tcttaaccct gcatccactt gcaacactaa acatcaacct gggcttttcc 
–317 acctaactcc atctcggcca ccgtactggt ctcggttgaa gaagagagag 
–267 ttaggaagcg ctcaagcgca gacgcaacct gggtgctgga cggggaaact 
–217 gaggtctggc tctgaggcgt cacccctcgc cgcgcgtgag caaccctggg 
–167 gttgtcaggc ctcgagtagg tacctggcgc tcgtgcccgg cccgcaacac 
–117 ttcctgtccc gcgcgcgtgc gatgctcatg tgacccggga ctgggcggag 
 -67 agcacctgaa cgaggacgtc acgtgagcag gaggcggggc gggggcgggc 
 -17 cgactcaggt cacgtgaCGC TCCGGGGACG GCCACGGAGC GCCTCCTCGT 
  34 CGCACTCCCC CCTGGCTCCA GTTCTCTCTC CTCTTTCTCC CTCCAGCTCC 
  84 CGTTGCAGCT 
 
 B
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. IGF-IIR promoter. 
(A) Promoter sequence of the IGF-IIR promoter 
Letters in bold indicate exon 1; counting starts at exon 1; underlined, bold sequences are potential
LEF-1 binding sites; dot marks start of the truncated form IGF-IIR-2, asterisk marks start of the
truncated form IGF-IIR-1.  
(B) Schematic diagram of the cloned IGF-IIR promoter fragments. 
 
4.1.4.2. Transfection assays of the IGF-IIR promoter to test LEF-1 
responsiveness 
 
For reporter analysis the IGF-IIR promoter (Figure 10B) and the IGF-IIR-1 
construct (Figure 10A) were chosen and the luciferase activity monitored after 
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Lef1, Lef1/β-catenin, CatCLef, and VP16Lef1 transfection. VP16Lef1 is a construct 
where a viral promoter is fused to LEF-1 and therefore LEF-1 is constitutive active. 
No specific effects could be detected, as the weak repression detected after LEF-
1/β-catenin or CatCLEF expression was only occurring with the shortened 
promoter construct, which should be less responsive than the full length IGF-IIR 
promoter. A titration for LEF-1 dependent repression was carried out using 
increasing amounts of LEF-1 together with the full-length construct (Figure 10C). 
The upregulating effects occurring are most likely due to unspecific activation of 
the promoter and do not display a specific effect, as the same effect was also 
observed for the shortened construct (data not shown). In summary no effect on 
the IGF-IIR promoter could be detected after Lef1 transfection.  
 
 
4.1.4.3. Stable integration of the IGF-IIR promoter in NIH3T3 cells 
 
The fact that we could not detect any regulation of the IGF-IIR promoter after LEF-
1 expression could be due to the necessity of a stable integration of the promoter 
into the genome, as chromatin has also an influence on regulatory effects. 
Therefore, the full length promoter construct carrying the three LEF-1 binding sites 
driving the firefly luciferase was stably integrated into NIH3T3 cells. The promoter 
construct was linearized and together with a linearized plasmid carrying the 
resistance for neomycin co-transfected into NIH3T3 cells. One day post 
transfection, the culture was supplemented with neomycin and stable pools were 
created. The different pools were tested for luciferase activity to ensure that the 
IGF-IIR promoter was inserted. Three different pools with high luciferase activity 
could be detected. To test the stable cell pools for LEF-1 dependent repression, 
the cells were transfected with different plasmids carrying either a CatCLEF-IRES-
eGFP, a ∆56LEF-IRES-eGFP, an HMG-IRES-eGFP, only containing the HMG 
domain of LEF-1, or the empty plasmid IRES-eGFP for control. After 48 hours 
GFP positive cells were sorted to obtain only cells that were transfected with the 
different plasmids. CMV-βgal was always co-transfected for normalization. The 
experiment was carried out five times and two representable  
Results   60 
 
 
 2 2  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
F
N
t
µ
a
t
p
d
A
IGF-IIR prom +    +     +     +     +    + 
LEF-1 -    +     +     -     -    - 
β-catenin -    -     +     +     -    - 
CatCLEF-1 -    -     -     -     +    - 
VP16LEF-1 -    -     -     -     +    - 
0.5
1
1.5
Fo
ld
 c
ha
ng
e
 
0
0
0.5
1
1.5
2
2.5
3
Fo
ld
 c
ha
ng
e
 
IGF-IIR prom + +  + +   + 
LEF-1  -      - 
β-catenin - +  +  +   - 
CatCLEF - -  -  -  
igure 10. Promoter analysis of the IGF-IIR promoter. 
IH3T3 cells were transfected with calcium-phosphate with 50
he full length IGF-IIR promoter (B) together with plasmids ex
g), CatCLEF (30 ng), and VP16LEF-1 (30 ng). To test whe
re necessary for repression of the promoter, increasing am
ogether with β-catenin (1 µ g) or CatCLEF (30, 100, 300 ng) w
romoter. When using the highest amounts of LEF-1/CatC
etected, but this is most likely an unspecific activation. B
R IGF-IIR-1       +
       -
       -
       -
       -
0.5
1
1.5
Fo
ld
 c
ha
ng
e
0
  +    + 
  -    - 
  -    - 
 ng of the IGF-I
pressing LEF-1 (
ther higher LEF
ounts of LEF-1
ere transfected
LEF some upIGF-II     + 
     - 
     - 
     + 
     - C
IR-1 promoter (A) or
30 ng), β-catenin (1
-1 expression levels
 (30, 100, 300 ng)
 using the full-length
regulation could be
Results   61 
 
 
 
measurements are shown (Figure 11). No repression could be detected. As the 
weak upregulation sometimes observed after CatCLEF transfection only occurred 
randomly and was not reproducible (only in experiment B, not in A), it is most likely 
that this effect is due to an unspecific effect. Neither ∆56LEF nor the HMG domain 
changed the measured luciferase levels. The stable integration of the IGF-IIR 
promoter into NIH3T3 cells did not help to observe the repressive effect we wanted 
to examine. 
  A
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Figure 11. Effects of LEF-1 expression on 
promoter. 
A stable pool of NIH3T3 cells expressing IG
∆56LEF-IRES-eGFP, CatCLEF-IRES-eGFP, HM
for control. 48 hours after transfection the cells 
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translated protein is kept inactive in the cytoplasm due to the ER signal. After 
addition of estrogen to the cells, the protein translocates into the nucleus where it 
becomes active and regulates target genes. To obtain higher cell numbers for 
further analysis we decided to use the estrogen system together with a retroviral 
system, thus infecting the IGF-IIR stable NIH3T3 cells with the different LEF-1 
constructs. For this purpose two NIH3T3 IGF-IIR cell pools (I+II) were infected with 
retroviral vectors carrying either CatCLEF-ER or ∆56LEF-ER. The infected pools 
were selected with neomycin for IGF-IIR and zeocin for the retroviral vectors. We 
obtained homogenous cell pools expressing equal levels of the IGF-IIR promoter 
driving the luciferase as well as equal levels of the inducible CatCLEF-
ER/∆56LEF-ER. To ensure that LEF-1 is inactive without the addition of estrogen, 
a special estrogen free serum was used that was stripped with activated charcoal 
which binds estrogen. The inducibility of the established system was tested by 
preparing nuclear and cytoplasmic extracts of induced and uninduced cells. The 
extracts were used in an electro mobility shift experiments with a LEF-1 probe 
containing a LEF-1 consensus site. By incubation of the extracts with the LEF-1 
probe we could also test if the system was leaky (Figure 12A). To control if the 
extracts were properly prepared, the electro mobility shift experiment was carried 
out in parallel with a second probe, encoding a SP1 consensus site, binding the 
nuclear transcription factor SP1 that should only give a signal for the nuclear 
fraction. It could be shown that the fractions were prepared without any 
contamination between nuclear and cytoplasmic fraction and that the system is 
inducible and no leakiness is detectable taking into account that the faster 
migrating band is unspecific.  
The four different cell pools were induced for 40 hours with estrogen, the 
uninduced cells served as a control for regulation. The cells were harvested and 
normalized to total protein concentration and cell number. It could be shown that 
the different infected pools display different basal levels of luciferase activity, but in 
none of the infected pools a downregulation of the luciferase activity following 
induction could be observed (Figure 12B). 
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Figure 12. Responsiveness of LEF-1 infected NIH3T3 stable cell pools expressing the IGF-IIR
promoter driven luciferase. 
(A) Test of estrogen inducible LEF-1 expression. NIH3T3 cells infected with LEF-1-ER were grown
in media supplemented with dextran charcoal stripped serum to reduce the estrogen concentration
in the serum. Cytosolic and nuclear fractions were prepared and tested in an EMSA: As a control for
proper preparation of the extracts a probe was used that carried the consensus sequence for SP1
that is only expressed in the nucleus. The shift only occurs in the nuclear fraction (N) and not in the
cytosolic fraction (C): For LEF-1 a shift can only be detected with the induced nuclear fraction. ∆
indicates unspecific binding to the probes. 
(B) Analysis of two different NIH3T3 cell pools with the IGF-IIR promoter driving the luciferase stably
integrated (pool I+II) that were infected with CatCLEF-ER or ∆56LEF-1-ER (deltaLEF-ER). CatCLEF
and ∆56LEF-1 were activated following the addition of estrogen and induced and uninduced cells
were harvested 40 hours later. Luciferase activities were measured and normalized to the cell
number and the total protein concentration and are expressed as fold changes relative to the
uninduced CatCLEF-ER infected cell pool I. Besides the different base lines of the infected pools no
reproducible regulatory effects could be detected after activation of the proteins. 
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Because we could not detect any significant regulation of the IGF-IIR promoter 
following LEF-1 expression we concluded that either the regulatory effect of the 
IGF-IIR gene detected with the microarray screen cannot directly be ascribed to 
LEF-1 or the element through which the direct regulation occurs is an enhancer in 
a region different from the promoter we cloned.  
 
 
4.1.5. Pem endogenous regulation 
 
The oncofetal gene pem was another subject of interest. It was shown before that 
pem expression can be elevated by more than 50 fold in 10T1/2 cells by treating 
them with 5-Aza-cytidine (5AzaC) (Saski 1991). 10T1/2 cells are a mesenchymal 
stem cell line that can become committed to specific mesenchymal cell lineages, 
but they do not terminally differentiate unless the proliferative stimulus to the cells 
is removed. A large portion of 5AzaC treated 10T1/2 cells (25-50%) becomes 
myoblasts committed to the muscle cell lineage (Konieczyny 1984). Without 
stimulus 10T1/2 cells express a low but constitutive pem level. We decided to 
investigate if the change of pem expression levels in 5AzaC treated 10T1/2 cells 
also resulted in a change of LEF-1 levels. This would indicate whether the 
regulation of pem is tightly bound to LEF-1. On the other hand it is not clear why 
pem gets upregulated after 5AzaC treatment. There is still the possibility of a 
potential positive stimulus that gets activated through 5AzaC that can override the 
LEF-1 inhibiting mechanism.  
We were seeding out 10T1/2 cells very sparse and induced half of the samples with 
3 µM 5AzaC, the other half stayed untreated for control. Samples were harvested 
after 3, 5, and 7 days of induction. RNA was prepared, transcribed to cDNA, and a 
PCR for pem, Lef1, and GAPDH was performed (Figure 13). The experiment was 
repeated three times to rule out secondary effects. Pem was highly upregulated 
after 5AzaC treatment, but Lef1 levels stayed unchanged. 
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Figure 13. RT-PCR analysis of 10T½ cells treated with 5-Aza-cytidine (5AzaC). 
10T½ cells were treated with 3 µM 5AzaC for 3, 5, and 7 days. Untreated cells were used as control.
Cells were harvested after the indicated time points (3,5,7 days) and total RNA was prepared. The
RNA was transcribed to cDNA and a PCR with 25 cycles was performed for pem, Lef1 and GAPDH
as control. The experiment was repeated three times to rule out unspecific effects. Pem was
upregulated already 3 days after treatment. The Lef1 levels stayed unchanged during the treatment
phase. 
This analysis did not show a closer connection between LEF-1 and pem. 
Nevertheless, this does not rule out the possibility, that the regulation observed in 
the chip screen is direct. To further address that question, we would have to 
perform a promoter analysis. 
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4.2. T cells 
 
4.2.1. Arrest of T cell growth 
 
As a second approach we were analyzing LEF-1 target genes in T cells, thereby 
comparing the expression pattern in thymic cells of wildtype mice with those of 
Lef1-/- mice. It was shown before that T cell development in Lef1-/- mice is almost 
not altered (Okamura 1998). This is due to a redundancy of LEF-1 with other 
members of the LEF/TCF family like TCF-1. Only mice mutant for Lef1 and Tcf1 
have an almost complete block in T cell development, occurring after the immature 
single positive CD8+ (ISP CD8+) state.  
 
 
4.2.2. Microarray analysis of ISP CD8+ cells of wildtype and Lef1-/-
Tcf1(V)-/- mice 
 
4.2.2.1. Sorting of ISP CD8+ cells 
 
For studies of genes regulated by LEF-1 in T cells, we were choosing Lef1-/-
Tcf1(V)-/- mice, as the redundancy of LEF-1 with TCF-1 does not allow direct 
investigation of expression level changes in the Lef1-/- knockouts. To observe 
changes in gene regulations due to the lack of LEF-1/TCF-1 we worked with a 
specific cell population that is present in both wildtype and mutant mice, in order to 
rule out the possibility, that changed expression levels are a result of changed 
proportions of the cell pools. Because in Lef1-/-Tcf1(V)-/- mice the T cell 
development stops at the ISP CD8+ stage, is this stage the last stage occurring in 
both mice lines. This makes it most likely that important regulatory processes are 
going on in this cell type. We sorted cells of the ISP CD8+ stage from wildtype and 
from Lef1-/-Tcf1(V)-/- E17.5 embryos. The analysis of those cells should unveil 
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important target genes. Fetal thymic organ cultures of wildtype and Lef1-/-Tcf1(V)-/- 
mice were first sorted for the lack of surface expression of CD4 and CD3. Cells 
that met these criteria were then further sorted for expression of CD8. The sort 
was carried out by R. Okamura. 
 
 
4.2.2.2. Linear Amplification of RNA 
 
For Affymetrix microarray analysis the amount of total RNA to start with was 
between 5 and 50 µg. The sort of the ISP CD8+ cells only resulted in very few 
cells. We could obtain 105 cells for wildtype and double null mice each. Therefore 
it was necessary to increase the RNA amount. To amplify the genes in a linear and 
therefore proportional range, a PCR amplification was not suitable as this results in 
an exponentially amplification. For this reason a linear amplification strategy was 
developed (Figure 14). The procedure was started as described by Coleman and 
coworkers (Eberwine 1992), using a poly-dT primer with a fused T7 promoter site 
to prime for the first strand cDNA synthesis. Following the first strand synthesis, 
the second cDNA strand was produced, resulting in an intact T7 promoter. For the 
in vitro translation (IVT) back to RNA, the T7 polymerase was used that could 
prime within the T7 promoter region. As the RNA produced after one round was 
still not enough for the microarray hybridization, we had to develop a method to 
further amplify the RNA. For that we were choosing to do another round of cDNA 
and in vitro transcription. As the poly-A tail of the total RNA is absent after one 
round of amplification, we could not use the poly-dT primer again. Therefore, we 
were starting the second round of amplification with random hexamer primers, 
followed by the poly-dT primer with a fused T7 promoter site for the second strand 
cDNA synthesis. This resulted again in cDNA that could be transcribed by the T7 
polymerase. This procedure was repeated once more, but this time biotinylated 
nucleotides were used for the last step, the IVT reaction, to obtain RNA with 
incorporated biotin. This biotin was detected by Streptavidin Phycoerythrin within 
the following staining process. Affymetrix later offered a similar protocol for the 
amplification of low RNA amounts.  
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Figure 14. Flow diagram for the procedure of linear RNA amplification. 
Total RNA of 10000 cells was transcribed to double stranded cDNA using a poly-dT primer with
the T7 promoter site fused. The in vitro transcription (IVT) reaction was carried out with the T7
polymerase. This procedure was repeated twice, taking random primer for the second cDNA
synthesis and biotinylated nucleotides for the third IVT reaction. 
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4.2.2.3. Microarray Hybridization and Scan 
 
The labeled cRNA was subjected to a fragmentation reaction to obtain small 
pieces with sizes between 100 to 200 basepairs. The cRNA was mixed with 
blocking reagents and standards for quality control and the reaction mixture was 
incubated for 16 hours on the microarray MGU74Avs2. Following hybridization the 
microarray was washed several times, stained and finally scanned. The whole 
procedure was carried out in an Affymetrix Fluidics Station. One gene is 
represented by 21 oligo-nucleotides. Specificity is controlled taking the ratio of the 
perfect match oligo-nucleotides to the mismatch oligo-nucleotide, which has one 
base mutated in the 20 basepairs spotted. The scanned image was controlled for 
proper alignment of the grid and intensities of the control genes (Figure 15). 
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Figure 15. Images of the scanned microarray. 
(A) Total view of the microarray MGU74Avs2 after scanning. 
(B) Control of the grid alignment in the left corner. 
(C) 21 spotted oligo-nucleotides representing one gene; upper row perfect match (PM), lower row
one mismatch (MM) in 20 bases of the oligo-nucleotide for specificity control. 
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4.2.2.4. Regulated genes 
 
The expression profiles of the two arrays, either probed with wildtype or Lef1-/-
Tcf1(V)-/- cells, were analyzed. The two chips were compared using the wildtype 
as the baseline. The experiment was repeated twice. 28 genes were detected to 
be upregulated at least three fold in Lef1-/-Tcf1(V)-/- double null cells in respect to 
wildtype cells and 63 downregulated at least three fold in Lef1-/-Tcf1(V)-/- double 
null cells (Table 2). Sequences of the ESTs were searched for homologies with 
known genes. 
 
Affymetrix 
ID number 
Fold 
Change 
Sort 
Score EST's homology Gene name 
98406_at 49 189.26  RANTES/small inducible cytokine A5 
93038_f_at 27 108.68  Lipocortin 1 
100468_g_at 16 79.37  LYL gene 
102185_f_at 13 46.74 Mouse lysosyme M gene  
102744_at 12 67.34  T-cell gamma gene 
95611_at 12 43.22 LP1 lipoprotein lipase  
95673_s_at 11 45.07 No homology  
97113_at 11 36.02  Fas antigen ligand 
102272_at 10 50.61  Natural killer cell BY55 precursor 
102695_at 9 30.09  T cell receptor gamma locus 
93013_at 8 35.44  Inhibitor of DNA binding 2  
104217_at 8 23.81 FLJ22603 fis (86%)  
93604_f_at 8 24.91  Immunosuperfamily protein Bl2 
103571_at 7 21.88  Lymphocyte specific transcript (LST) 
96047_at 7 27.2  Retinol binding protein (RBP) 
93534_at 7 18.26  Decorin  
100611_at 6 16.33  Lysozyme M gene  
102877_at 6 13.28  Granzyme B  
99214_at 6 12.66 C-C chemokine receptor 5  
93714_f_at 6 17.41 MHC class I  
95339_r_at 5 12.07  Macrophage metalloelastase 
96372_f_at 5 13.05 Acrogranin percursor  
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100944_at 5 24.32 No homology  
92328_at 5 32.05  T cell receptor delta chain. C region 
94887_at 5 35.93 No homology  
96172_at 4 22.46 No homology  
103451_at 3 7.84 No homology  
104079_at -3 -8.17 No homology  
95702_at -3 -7.69 No homology  
100212_f_at -3 -5.57 Cytokine inducible SH2-
containing protein 
 
100958_at -3 -5.73 No homology  
96791_at -3 -7.85 No homology  
98893_at -3 -5.52 No homology  
94367_at -3 -10.9 Uridine kinase  
96083_s_at -3 -16.21 Ribonucleoprotein D-like  
97411_at -3 -5.72  Ect2 oncogene  
96073_at -3 -5.13  Requiem 
101065_at -3 -11.94  Proliferating cell nuclear antigen 
94348_f_at -3 -6.11 No homology  
96135_at -3 -6.06 Homo sapiens PRO2013  
97250_at -3 -15.12 Homo sapiens Nop10p  
99607_at -3 -7.27  Transcription elongation factor B  
103267_i_at -4 -5.14 ZT2 gene zinc finger  
93254_at -4 -5.14 BCRL2  
93274_at -4 -7.07  CDC-like kinase 
97181_f_at -4 -9.32  IgE-binding factor 
103359_at -4 -5.51 No homology  
100720_at -4 -10.26  Poly(A) binding protein 
101081_at -4 -15.21  CtBP1 protein 
103667_at -4 -5.21 Homo sapiens polyA site DNA 
(85%) 
 
102838_at -4 -5.21  Lymph node homing receptor 
93255_at -4 -5.73  Ral-interacting protein 1 
94433_at -4 -5.03 Rattus norvegicus amino acid 
transporter system A 
(87%)+J85 
 
97312_at -4 -6.23  MGC-24v 
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93538_at -4 -5.78 Mus musculus Traf and Tnf 
receptor associated protein 
 
98981_s_at -4 -8.53  Transcription factor 12 
101958_f_at -4 -7.26  Transcription factor Dp 1 
97812_at -4 -7.5  B cell antigen receptor Ig beta 
associated protein 1 (IBAP-1) 
92513_at -4 -6.47  Nuclear protein SA2 
94192_at -4 -6.97  Ganglioside-induced differentiation 
associated protein 10 
102040_at -4 -7.8  G-protein coupled receptor kinase 6-
B 
104578_f_at -4 -22.72 
Human chromosome 14 DNA 
sequence 
 
102821_s_at -4 -10.93  Mouse (clone M2) GTPase (Ran) 
103634_at -4 -6.89  Interferon dependent positive acting 
Transcription factor 3 gamma 
103081_at -5 -7.49 No homology  
95994_at -5 -7.17 Mus Musculus Chromosome 
2 Clone RP23-291P1 
 
93511_at -5 -8.24  Integral membrane protein 2 
94788_f_at -5 -9.12  Beta-tubulin 
99086_g_at -5 -7.26 Homo sapiens ubiquitin 
specific protease 3(80%) 
 
104152_at -5 -7.51 No homology  
103562_f_at -5 -14.3  Endogenous retrovirus truncated gag 
protein 
92596_at -5 -11.28  Calcyclin binding protein (CACYBP) 
94027_at -5 -10.07 Mouse DNA for t-haplotype-
specific elements  
 
103753_at -5 -13.22 Homo sapiens cDNA 
FLJ10362 fis (89%) 
 
94830_at -5 -10.23 No homology  
92614_at -5 -6.67  Inhibitor of DNA binding 3 
95204_f_at -5 -12.11 Mouse beta D galactosidasae 
fusion 
 
96891_at -5 -13.69 Proliferation protein  
104343_f_at -6 -25.58 No homology  
Results   73 
 
 
 
100900_at -6 -16.15 Transcription factor C1  
97556_at -6 -15.42 Homo sapiens FLJ21971 fis  
97944_f_at -6 -25.73  T cell receptor alpha chain variable 
region  
99632_at -7 -18.07  Mitotic checkpoint component Mad2  
99665_at -7 -31.44  Nuclear matrix attachment DNA-
binding protein SATB1 
94835_f_at -8 -23.03  Tubulin, beta 2 
93637_at -9 -28.66  CD5 antigen 
102539_at -9 -31.07 T cell differentiation antigen 
(Ly3) 
 
96302_at -10 -32.87 Homo sapiens splicing factor  
98756_at -13 -46.66 No homology  
96609_at -16 -62.08 Rat casein kinase II   
 
 
Table 2. List of genes regulated more than 3-fold in both directions found in the T cell screen.
 
 
4.2.3. Validation of target genes by real-time PCR 
 
The list of regulated genes was further reduced. The genes strongest regulated in 
both directions were examined. We decided to concentrate on the full-length 
genes and keep the ESTs for later analysis. For the repressed genes we wanted 
to analyze potential targets that were at least 11-fold regulated. Therefore we were 
selecting RANTES, Lipocortin, LYL, and Fas antigen ligand (FasL) for validation. 
T-cell gamma we did not include in our analysis, as the sequences for the spotted 
oligo-nucleotides were not published up to this date, and we could not distinguish 
between the different variable forms existing. As the genes activated through LEF-
1 were only to lower levels regulated as compared to the repressed genes, we 
were choosing potential target genes that were at least 7-fold regulated. The 
positively regulated genes included in our validation were CD5, SATB1, and Mad2. 
Tubulin-β was not included in the validation due to similar reasons as the T cell-γ. 
For tubulin-β many isoforms were identified. As we did not have the spotted 
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sequence, we could not rule out, which of the isoforms was regulated, or whether 
all isoforms showed this effect.  
Real-time PCR was performed out of 105 ISP CD8+ cells of wildtype and Lef1-/-
Tcf1(V)-/- mice for the selected genes. Total RNA was transcribed to cDNA and 
was used unamplified for the quantitative PCR reaction. TCRα, an already 
published target gene (Travis 1991), was selected as a positive control. Lipocortin, 
LYL, and Mad2 could not be detected before 40 cycles, neither in the cDNA out of 
wildtype cells nor in the cDNA out of Lef1-/-Tcf1(V)-/- double null cells, because of 
the low cDNA amount used (data not shown). This is probably due to lower 
abundance of these genes in the ISP CD8+ cells as compared to the other genes 
selected for validation. RANTES, FasL, SATB1, and CD5 could be detected and 
were found to be regulated as seen with the microarray analysis (Figure 16). 
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chip dataFigure 16. Validation of the T cell screen results by real-time PCR. 
Total RNA of sorted, unamplified ISP CD8+ cells of wildtype and Lef1-/-Tcf1(V)-/- double null mice
was prepared, transcribed to cDNA and endogenous levels of the target genes were evaluated by
real-time PCR. RANTES, Fas Ligand, SATB1, and CD5 could be shown to be regulated. TCRα
served as positive control, as it was already shown to be regulated by LEF-1. 
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RANTES, the small inducible cytokine 5, is expressed only late in T cell 
development. The induction occurs about five days after activation of peripheral 
blood monolayer cells (PBMCs) (Schall 1988). RANTES Factor of Late Activated T 
Lymphocytes-1 (RFLAT-1) was shown to be necessary for activation of RANTES 
in T cells (Song 1999) but it is still unclear why the onset of this cytokine occurs so 
late compared to other cytokines. There is the possibility that an active suppressor 
for RANTES exists. Since RANTES belongs to the same cytokine family as MCP-
1, a target identified with the NIH3T3 screen, and both are found to be deregulated 
independently, the question arises if the whole family of this type of cytokines is 
regulated through LEF-1. 
Fas antigen ligand (FasL) is a tumor necrosis factor (TNF) related type II 
membrane protein and binds to Fas. It is expressed in highly activated T-
lymphocytes (Nagata 1999; Pinkoski 1999). Activated T-lymphocytes undergo 
apoptosis following homotypic interaction of FasL and its receptor, Fas (Brunner 
1995; Dhein 1995; Ju 1995). Thus, the elimination of highly activated T-cells by the 
Fas/FasL system is critical for the downregulation of immune responses, the 
homeostasis of lymphocytes, and the maintenance of peripheral tolerance. FasL, 
the second gene negatively regulated by LEF-1 that we validated is also highly 
expressed in activated T cells, making it possible that the regulation is direct, as 
LEF-1 is only highly expressed in the developing T cell and is almost not 
detectable in PBMCs, with or without activation. 
CD5 (Ly-1) is a pan-T marker present at higher levels on helper T cells than on 
suppressor or cytotoxic T cells. Little is known about the role of CD5 in lymphocyte 
function and/or differentiation. Antibodies against CD5 can augment alloantigen- or 
mitogen-induced lymphocyte proliferation, suggesting a possible role for CD5 in 
regulating T-cell proliferation (Hollander 1981; Loydberg 1985). As LEF-1 is also 
clearly connected to the proliferation of T cells it seems to be likely that those two 
genes are interdependent. 
SATB1, a MAR-binding protein is known to regulate expression of multiple genes 
during T-cell development. It was also found to be downregulated in Lef1-/-  
Tcf1(V)-/- T-cells, indicating that it is normally upregulated by LEF-1. SATB1 
knockout mice develop a thymic phenotype similar to that found in Lef1-/-Tcf1(V)-/- 
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mice. The thymus is highly reduced in size and there is a block in T-cell 
development (Alvarez 2000). Nevertheless the block occurs at a later stage than it 
was seen in Lef1-/-Tcf1(V)-/- mice. SATB1 null mice can still develop double 
positive cells but further development is greatly reduced. The later onset of the T 
cell developmental block in SATB1 mice could be a hint that SATB1 is indeed lying 
downstream of LEF-1, making it an interesting target for further analysis. 
 
 
4.2.4. Correlation of LEF-1 expression with the expression of the 
putative target genes 
 
The endogenous levels of the target genes were analyzed in different cell lines to 
examine relative expression levels of the target genes and LEF-1. This can 
already be an indication whether the regulation detected on the microarray and 
validated by real-time PCR is also occurring naturally in transformed cell lines. We 
were expecting to find high expression levels of SATB1 and CD5 in cell lines 
expressing high LEF-1 levels and low in those cell lines where LEF-1 is almost not 
detectable. RANTES and FasL were supposed to behave the opposite way. For 
the analysis two different T cell lines were chosen. On the one hand we were 
examining Jurkat cells, a mature T cell line without activated features, on the other 
hand Hut78 cells, also a mature T cell line, but this cell line is already displaying 
features of activated cells such as the presentation of the IL2 receptor on the 
surface. The levels of LEF-1 in those cell lines were determined by immunoblot 
analysis, using Hela cells as a negative control. It could be shown that LEF-1 is 
expressed at high levels in Jurkat cells and cannot be detected in Hut78 cells 
(Figure 17A). The expression levels of the targets were examined by real-time 
PCR. SATB1 and CD5 are expressed highly in Jurkat cells and at lower levels in 
Hut78 cells, whereas FasL and RANTES behave vice versa (Figure 17B). 
Expression of RANTES and FasL seemed to be almost completely blocked in 
Jurkat cells as their levels are only few cycles above the background, indicating an 
active repression. The strong regulatory effects found for RANTES and FasL 
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expressing the levels as fold change relative to the cell line expressing the genes 
only at low levels, the Jurkat cells, are contradictionary to the modest regulation 
observed for SATB1 and CD5. This might be due to the fact that the expression 
level of SATB1 and CD5 are lower in Hut78 cells, but are still clearly detectable 
above background, indicating that an active repressor might be missing in Hut78 
cells to completely abolish the expression of SATB1 and CD5 or that they can also 
get activated by other LEF/TCF family members. We also examined the protein 
levels for SATB1. The analysis revealed the same as seen at RNA levels and is 
overlapping with the expression profile of LEF-1 (Figure 17A).  
RANTES is highly expressed in other tissues besides T cells, but they are always 
low on LEF-1 expression (data not shown). 
 
 
          A
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17. Endogenous expression levels of target gene
(A) Protein levels of LEF-1, SATB1, and Lamin B as l
cells. LEF-1 and SATB1 are present in Jurkat cells, but
cells detectable. 
(B) RNA levels of RANTES, FasL, SATB1, and CD5 in
time PCR. RANTES and FasL are not detectable in Ju
Hut78 cells. SATB1 and CD5 are behaving vice versa
levels in Hut78 cells. The values are denoted as fold ch
expression levels are detected.   B Jurkat Hut78 
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4.2.5. Endogenous upregulation of CD5 and SATB1 after trans-
fection of Lef1 and β-catenin 
 
To study the regulation of CD5 and SATB1 in more detail, Lef1 and β-catenin were 
transfected into Hut78 cells. As shown before, this cell line is expressing only low 
levels of LEF-1, SATB1 and CD5. Hut78 cells were electroporated either with an 
empty vector carrying IRES-eGFP as control or with LEF-1-IRES-eGFP together 
with a plasmid encoding  β-catenin. The cells were sorted after 24 hours for GFP 
expression and RNA was prepared. After reverse transcription the cDNA was 
analyzed by real-time amplification. LEF-1 protein levels were analyzed to verify 
the LEF-1 expression in LEF-1-IRES-eGFP transfected cells (Figure 18A). It could 
be shown that after 24 hours the CD5 level was upregulated 8-fold and the SATB1 
level 12-fold (Figure 18C). To analyze how fast the upregulation occurs, this 
experiment was repeated but this time the cells were already sorted 12 hours post 
transfection. CD5 and SATB1 were still found to be upregulated (Figure 18B), 
leading to the conclusion that they are most likely directly regulated by LEF-1. 
Nevertheless it cannot be ruled out that the regulations are due to secondary 
effects. 
 
 
4.2.6. Endogenous levels of LEF-1 and RANTES in peripheral 
blood monolayer cells (PBMCs) 
 
It was shown before that RANTES could be induced with the mitogen 
phytohemaglutamine (PHA-P) (5 µg/ml) in peripheral blood monolayer cells 
(PBMCs) (Schall 1988). RANTES reaches the maximum level 5 days after the 
induction. RFLAT, a positive regulator of RANTES was shown to get 
posttranscriptionally modified shortly before the upregulation occurs (Song 1999), 
indicating that the activation is driven by RFLAT.  
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Figure 18. Regulatory effects after transfection of plasmids expressing LEF-1 and β-catenin into
Hut78 cells measured by real-time PCR. 
Hut78 cells were transfected with plasmids expressing LEF-1-IRES-eGFP and β-catenin or the
empty plasmid IRES-eGFP (MCS) as control.  
(A) The expression of LEF-1 in transfected cells was controlled by an immunoblot.  
(B), (C) Endogenous SATB1 and CD5 levels were examined by real-time PCR sorting the cells 12
(B) or 24 hours (C) after transfection for GFP positive cells. CD5 and SATB1 were found activated
in both cases. The levels are expressed as fold change relative to the mock transfected sample. 
 
We examined whether LEF-1 also plays a role in the induction and whether the 
upregulation of RANTES is accompanied by LEF-1 downregulation. We isolated 
PBMCs out of 150 ml human blood and seeded them onto culture dishes. Half of 
the cells were induced with PHA-P (5 µg/ml), the other half was kept untreated as 
control group. The cells were checked for activation after 3 days by FACS 
measurement, staining the surface marker of the T cell marker CD3 and the 
activation marker CD25 (Figure 19A). The majority of the uninduced cells was 
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found to be not activated, whereas 81.5% of the cells were found active 3 days 
after induction. Cells of the induced and control group were harvested at 0, 1, 3, 5, 
and 7 days after the induction. The RNA levels of RANTES and LEF-1 were 
examined by real-time PCR in uninduced and induced cells (Figure 19B). An 
upregulation of RANTES could be shown starting at day 5, Lef1 levels were very 
low and almost not higher than the background over the whole period, but they 
also showed a weak upregulation. 
We ruled out the possibility that LEF-1 is regulated posttranscriptionally and is 
influencing RANTES levels by modifications at the protein level, as RFALT is only 
posttranscriptionally regulated and its RNA levels are staying constant after 
activation of PBMCs (Song 1999). We were performing an immunoblot against 
LEF-1 to determine the LEF-1 protein levels (Figure 19C). LEF-1 was hardly 
detectable because there is almost no protein translated in PBMCs and no obvious 
change in the protein levels during the activation occurred. This makes it unlikely 
that LEF-1 is involved in the process of the late upregulation of RANTES in 
PBMCs. Nevertheless, this finding is not a proof that there is no direct repression 
of RANTES by LEF-1, it just shows that there is no automatic upregulation of 
RANTES if LEF-1 is not expressed at high levels. The question of a direct effect of 
LEF-1 expression on RANTES repression had to be addressed in a promoter 
analysis. 
 
 
4.2.7. RANTES promoter 
 
LEF-1 was shown before to positively regulate target genes. Mostly LEF-1 has to 
interact with β-catenin to turn on genes. So far not much is known how LEF-1 can 
repress genes. A recent study showed that LEF-1 together with β-catenin could 
repress E-cadherin (Jamora 2003). But as described before, it is still unclear 
whether β-catenin is really necessary for active repression or just for the  activation  
of the co-repressor. The effects reported in the E-cadherin analysis are only 2-fold, 
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therefore it is possible that a co-repressor is missing in order to obtain greater 
regulatory effects.  
As one third of the genes found to be regulated in our T cell screen appeared to be 
negatively regulated by LEF-1, we examined whether the repression is directly 
mediated by LEF-1. To analyze this, we choose the Rantes gene as this is 
involved in many severe diseases like asthma, HIV and others and has a well 
characterized promoter. 
The RANTES promoter was already cloned out of the mouse and out of the human 
genome (Nelson 1993; Danoff 1994). Human and mouse RANTES are ortholog 
genes that show significant sequence similarity within their coding region. 
However, alignment of the two promoters showed that the promoter regions are 
not conserved. In mouse, RANTES does not bind to the same receptors as in 
human (Gao 1995; Gao 1997). Facing this problem we decided to clone the 
human and the mouse promoter, as we did not know if the regulation only works 
by combining mouse cells and mouse promoter and vice versa. 
 
 
4.2.7.1. Cloning of the mouse RANTES promoter 
 
The mouse RANTES promoter (Danoff 1994) has two strong and one weak LEF-1 
binding site. It was shown before that the minimal active promoter is only 175 
basepairs long, but to be able to detect repression we cloned a long promoter 
piece consisting of 1041 basepairs including all three LEF-1 consensus motifs in 
front of the firefly luciferase (Figure 20A). To be able to distinguish between 
unspecific effects and LEF-1 depending effects on the promoter we mutated the 
two strong LEF-1 binding sites by site directed mutagenesis and also cloned a 
truncated form lacking all three LEF-1 binding sites (Figure 20B). 
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  A 
-1041 aagcttgact ctggactagg acctcaacaa agaataaggc ggagcatgat  
 -991 tgaatgctaa gcatcctcct gtgcccacca ttcacacact gattgaatgt  
 -941 taggcatcct cctgtgccca ccattcacac acatgcgcac atacacatgc  
 -891 acacacatgc acacacacat gtacacacat gcacacacat gcacacacat  
 -841 atgtacacac acatgtacac acacacatgc acacacacat gcacacacac  
 -791 acacacacac acacacacac acacacacac tttttttaaa tctttatttc  
 -741 cacagagatt ctttgtagcc ctatcagatc ccttgactcc tagacaaaca  
 -691 gacagacaga cagacaataa atagatatta cagatagata atagatggac  
 -641 atagaggaca caactctttt gttcccatct tagttactaa tgttaactct  
 -591 cagatcacat gtcacacact aagtgtaagt atgcctatat ctacctagtt  
 -541 atctgggaat caggattacc tggcaaattc cttacaacaa atctcctata  
 -491 ccttgttaac ttattgttat caatgacaca agtgtggtct gtttctgata  
 -441 tggtatgctc atgacaaata ctcttccatg gagaaaacag aaagaccaaa  
 -391 atcaagtctg ggctacaact tgggaatttg ccaagtgaag accaatggct  
     • 
 -341 tgaccttaac tgacccctac ttgccttaag acaacagctc cctgctacct  
 -291 ggagaggccc tgagtgggac ggcagatctg agggggaggg ggagggggag  
 -241 gaagaaattt tcccctactg tatttggcca gagagggagt catcctggac  
 -191 tggagggcag ttagaggcag agtcatactt ccaagggtga tttcagtttt  
 -141 cttttccatt ttgtgttttc attttatgac agcaacaagt gtttggtgtc  
  -91 ttttgtggaa actccccaag tcctggggct gggggggggc acttcctctg  
  -41 ctaccctggc tccctataaa aggtctgcct gagctgcaga gCACCCCTTG  
   10 CAGAGGACTCT GAGACAGCAC ATGCATCTC CCACAGCCTC TGCCGCGGGT  
    ↓ 
   50 ACCATGAAGA TCTC 
  B Wildtype –1100 gacctcaacaaagaataaggcg 
 Mutant    –1100 gacctcaacgaattctaaggcg 
 Wildtype –725 agattctttgtagccctatcag 
 Mutant    –725 agattccttaaggccctatcag 
 
  C
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20. DNA sequence and consensus elements of the mouse RANTES promoter. 
(A) Cloned mouse RANTES DNA sequence including 991 basepairs of the promoter region. Exon in
capital letters; the transcription start site has been designated +1. Arrow denotes the translation start
site. The TATA box at –27 has been double underlined. Bold underlined sequences represent the
LEF-1 binding sites. Dot represents start site of truncated form mRANTES278. 
(B) Strong LEF-1 consensus sites with the mutated sequence. 
(C) Schematic diagramm of the mRANTES promoter constructs. In mut2RANTES were the two
strong LEF-1 binding sites mutated (Mut), mRANTES278 is the truncated form, missing all LEF-1
binding sites. 
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4.2.7.2. Cloning of the human RANTES promoter 
 
The human RANTES promoter (Nelson 1993) has even more perfect LEF-1 
binding sites. Two are identical to the site found in TCRα, a gene that was shown 
to interact with LEF-1, and two are less perfect. We cloned the promoter piece 
including all four LEF-1 binding sites in front of the firefly luciferase (Figure 21A) 
and performed site directed mutagenesis with all four sites resulting in a four point 
mutated promoter (Figure 21B). 
 
 
4.2.7.3. Analysis of the LEF-1 binding sites by Electro Mobility Shift 
Assay (EMSA) 
 
The two major LEF-1 binding sites of the mouse promoter were analyzed for LEF-
1 binding capacity using an electro mobility shift assay (EMSA). Recombinant 
LEF-1 was tested with the two wildtype LEF-1 binding sites and their mutants for 
activity (Figure 20B; 22A). It could be shown that LEF-1 binds to the wildtype sites 
whereas for the mutated sites no binding could be detected. LEF-1 binds to site    
–725 with almost comparable strength as to the TCRα positive control, whereas 
the binding to site –1100 is detectable but not as strong as seen for the other site 
or the positive control. 
We also tested the binding capacity of LEF-1 to the sites of the human promoter. 
As site –942 and –376 are identical and sites –667 and –209 are almost the same, 
we tested sites –942 and –676 as representatives (Figure 21B; 22B). LEF-1 was 
shown to bind with at least the same strength to site –942 as to TCRα, whereas 
the binding to site –667 was only weakly detectable. The mutated site –942 was 
bound poorly by LEF-1, approximately to the same extent as site –667. The 
remaining binding activity can be explained with another less perfect LEF-1 
binding site (-934) next to the mutated perfect match consensus site. 
A direct regulation of the RANTES promoter through LEF-1 seems possible, 
because LEF-1 can bind in the promoter region. 
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  A
 
-961 gtcgaggatc cctaaagtcc tttgaagctt tcatattctg taacttttgt  
-911 gccaagaagg ccttacagtg agatgggatc ccagtattta ttgagtttcc  
-861 tcattcataa aatggggata ataatagtaa atgagttgac acgcgctaag  
-811 acagtggaat agtggctggc acagataagc cctcggtaaa tggtagccaa  
-761 taatgataga gtatgctgta agatatcttt ctctccctct gcttctcaac  
-711 aagtctctaa tcaattattc cactttataa acaaggaaat agaactcaaa  
-661 gacattaagc acttttccca aaggtcgctt agcaagtaaa tgggagagac  
-611 cctatgacca ggatgaaagc aagaaattcc cacaagagga ctcattccaa  
-561 ctcatatctt gtgaaaaggt tcccaatgcc cagctcagat caactgcctc  
-511 aatttacagt gtgagtgtgc tcacctcctt tggggactgt atatccagag  
-461 gaccctcctc aataaaacac tttataaata acatccttcc atggatgagg  
-411 gaaaggagat aagatctgta atgaataagc aggaactttg aagactcagt  
-361 gactcagtga gtaataaaga ctcagtgact tctgatcctg tcctaactgc  
-311 cactccttgt tgtccccaag aaagcggctt cctgctctct gaggaggacc  
-261 ccttccctgg aaggtaaaac taaggatgtc agcagagaaa tttttccacc  
-211 attggtgctt ggtcaaagag gaaactgatg agctcactct agatgagaga  
-161 gcagtgaggg agagacagag actcgaattt ccggaggcta tttcagtttt  
-111 cttttccgtt ttgtgcaatt tcacttatga taccggccaa tgcttggttg  
 -61 ctattttgga aactcccctt aggggatgcc cctcaactgg ccctataaag  
 -11 ggccagcctg aGCTGCAGAG CGATTCCTGC ACGAGGATCA AGCACAGCA 
 
 
  
Wildtype -942  5’ tccctaaagtcctttgaagctttcatattc 3’ 
Mutant    -942  5’ tccctaaagtgaattcaagctttcatattc 3’ 
Wildtype -667  5’ aggaaatagaactcaaagacattaagcac 3’ 
Mutant    -667  5’ aggaaatagaactgaattccattaagcac 3’ 
Wildtype -376  5’ aataagcaggaactttgaagactcagtgactca 3’ 
Mutant    -376  5’ aataagcaggagaattcaagactcagtgactca 3’ 
Wildtype -210  5’ attggtgcttggtcaaagaggaaactgat 3’ 
Mutant    -210  5’ attggtgcttggtgaattcggaaactgat 3’ 
 
  
 
 
 
 
 
 
 
 
 
Figure 21. DNA sequence and consensus elements of the human RANTES promoter. 
(A) Part of the human RANTES gene including 961 basepairs of the promoter. Exon in capital
letters. The transcription start site has been designated +1. Bold, underlined sequences represent
the LEF-1 binding sites. 
(B) LEF-1 consensus sites with the mutated sequence. 
(C) Schematic diagram of the hRANTES promoter constructs. In mut4hRANTES were all four
LEF-1 binding sites mutated (Mut). B
C
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Figure 22. EMSA to determine binding capacity of LEF-1 to the binding sites in the mouse and
human RANTES promoter. 
(A) Oligo-nucleotides encompassing a perfect LEF-1 consensus site (TCRα) and the two good
LEF-1 binding sites (-1100, -725) of the mouse RANTES promoter were labeled with 32P. 30, 50,
and 100 ng of recombinant LEF-1 were used together with 10000 cpm of the probe to test for
binding capacity of the two binding sites in comparison to the control. LEF-1 binds to the –725
consensus motif as good as to the control, –1100 is found to be bound with lower capacity. No
binding could be detected for the mutated sites. 
(B) The binding of LEF-1 to two representative sites of the human RANTES promoter (site –942,
site –667) was tested. The probes were labeled with 32P and 30 ng of recombinant LEF-1 were
used together with 10000 cpm of the probe for the band shift. With site –942 LEF-1 shows at least
equal binding strength as with TCRα, but the site –667 was only weakly bound. LEF-1 is still able
to shift the mutated site –942, probably due to another minor LEF-1 consensus site next to the
mutated one. 
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4.2.7.4. Transfection assays to test LEF-1 responsiveness of the 
RANTES promoter 
 
The cloned mouse and human promoter driving the firefly luciferase were tested 
for activity in Jurkat cells. Both promoters were found to be active (data not 
shown). Therefore, we conducted the next experiments concentrating on the 
mouse promoter. As shown before, LEF-1 is expressed at high levels in Jurkat 
cells. We first compared the basal levels of the wildtype mouse promoter and the 
mut2RANTES mouse promoter (Figure 23A). If LEF-1 alone is responsible for the 
repression, we could expect higher levels for the mutated promoter. 1 µg of the 
mouse wildtype and the mouse mutated RANTES promoter were transfected into 
Jurkat cells and the luciferase activity was measured. The experiment was 
conducted in duplicate and repeated several times. The mutated promoter 
behaved the opposite as we expected and it was found to have a lower basal level 
than the wildtype one. This could be due to the absence of interaction partners, 
necessary for the repression. Next we tested the effect of Lef1, β-catenin or both 
on the mouse wildtype RANTES promoter in Jurkat cells (Figure 23B). After β-
catenin expression we could detect an upregulation, less than 1.5-fold that was 
pronounced if we coexpressed LEF-1. As this regulation was not strengthened 
when we were transfecting more β-catenin and never exceeded 1.7-fold, we were 
accounting this effect as not significant. After transfection of higher amounts of 
LEF-1 together with β-catenin, a repression could be detected, getting stronger 
when we were expressing more of β-catenin but not exceeding 1.8-fold. As in this 
effect the increasing amounts used are reflected in the repression pattern, we 
concluded that the weak repression might be real and went on with the analysis of 
the RANTES promoter. 
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mRANTES +   +   +   +    +   +   +    +   +   +   + 
LEF-1 -            -    -   -   +    +   
β-catenin -   -   -                   
 
wt RANTES +    - 
mut2RANTES -    + 
 
 
 
 
 
 
 
 
 
Figure 23. Mouse RANTES promoter analysis in Jurkat cells. 
(A) Promoter activity of the wildtype and the double mutant mouse RANTES promoter (mut2
RANTES). Electroporation was used to transfect Jurkat cells with two different RANTES promoter-
luciferase constructs in the pGL-3 vector backbone. Cells were transfected with 1 µg of each
plasmid and luciferase activity was determined 36 hours after transfections. Luciferase activity is
expresses as fold change relative to the activity of the wildtype promoter. The mutated promoter
showed a lower basal level compared to the wildtype promoter. 
(B) LEF-1 can repress RANTES promoter activity by 1.8-fold. 1 µg mRANTES reporter construct
were transfected together with increasing amounts of expression constructs encoding for LEF-1
(1, 3 µg) and β-catenin (1, 3, 10 µg). The luciferase activity is expressed as fold change relative to
the level of luciferase activity from cells transfected with the promoter alone. No significant effect
could be detected with LEF-1 and β-catenin expression alone. Co-expression showed a weak
repression of the promoter activity. 
 
Since Jurkat cells have high levels of endogenous LEF-1 and are also expressing 
β-catenin, we were choosing Hut78 cells for further analysis of the RANTES 
promoter, because those cells express almost no LEF-1 as shown previously. The 
human and the mouse RANTES promoter were also active in this cell line, even at 
a 2- to 3-fold higher level than in Jurkat cells (data not shown). We co-transfected 
the cells with Lef1, β-catenin, and both of them, using the mouse and the human 
RANTES wildtype promoter to rule out the possibility that the mouse promoter is 
not getting regulated in a human environment. With the mouse RANTES promoter 
no significant changes could be detected (Figure 24A), whereas with the human 
promoter a weak (less than two fold) but reproducible downregulation could be 
seen when LEF-1 and β-catenin were both expressed (Figure 24B). 
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normally represses RANTES, as the upregulation will probably never occur in vivo 
simply due to the fact, that LEF-1 is normally never expressed in fibroblasts.  
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Figure 25. Mouse RANTES promoter analysis in NIH3T3 cells. 
NIH3T3 fibroblasts were transfected by CaCl2 with 100 ng of the mRANTES promoter or the
truncated form (mRANTES278) together with plasmids expressing LEF-1 (100 ng) and β-catenin
(1 µg) in combination or alone. Luciferase activity is expressed as fold changes relative to the
promoter alone. For both promoters we could detect activation, pronounced after cotransfection of
Lef1 alone.  
Although we could not detect any changes in the LEF-1 levels after activation of 
PBMCs, we wanted to test the human RANTES promoter in primary T cells, as 
sometimes effects are more obvious in untransformed cells. The PBMCs were 
purified out of whole blood and split into two groups. One group was kept as 
control group and stayed untreated, the other group we activated with the mitogen 
PHA-P (5 µg/ml). After 24 hours of activation the cells were transfected with the 
hRANTES promoter. The control and induced group were harvested 36 hours post 
transfection and luciferase activity was measured (Figure 26A). In the control cells 
the promoter was not active, corresponding to the fact, that at this stage RANTES 
is not expressed. In activated cells the promoter showed activity. We further 
analyzed the regulatory processes in activated PBMCs by investigating the effects 
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of LEF-1 and β-catenin on the wildtype and the mutated human RANTES 
promoter. To distinguish between regulatory processes conducted by LEF-1 alone 
and regulations caused by the interaction of LEF-1 and β-catenin we were 
transfecting the m5-mutant of LEF-1, missing the β-catenin interaction domain, 
and LEF-1 together with β-catenin. The analysis revealed that m5LEF-1 could 
repress the wildtype promoter reproducible almost 2-fold, whereas activation is 
seen for the mut4hRANTES promoter (Figure 26B). This can be explained by the 
fact that there are indirect activating effects following Lef1 transfection as seen in 
the NIH3T3 reporter assay. Nevertheless, the lymphoid cells probably express the 
needed co-repressor, in contrast to NIH3T3 cells, so that the positive secondary 
upregulation effecting the wildtype RANTES promoter in PBMCs can be overruled 
with LEF-1 expression. Mutation of the LEF-1 consensus sites resulted in the loss 
of the repression and the indirect activating effect was visible. Transfection of LEF-
1 and β-catenin resulted in a 5-fold decrease of the wildtype promoter and a 2-fold 
of the mutated. The downregulation of the mutated promoter can be explained with 
two factors. First is one weak LEF-1 binding site still intact in the promoter as 
shown with the EMSA, where the mutated site was still bound by LEF-1. Secondly 
caused Lef1/β-catenin coexpression also a downregulation of the β-galactosidase 
readout, arguing that the effect is probably due to lower proliferation rates or onset 
of apoptosis. 
Taken together we can say that the regulation of RANTES is directly regulated by 
LEF-1 as we could detect clear differences between the wildtype and the mutated 
human RANTES promoter in PBMCs following LEF-1 expression. 
 
 
4.2.7.5. Transfection assays to test the effect of the co-repressor 
Groucho-1 together with LEF-1 on the RANTES promoter 
 
Groucho is a co-repressor that is known to interact with LEF/TCF proteins and 
helps to repress genes. It can  also  interact  with  other  DNA  binding  proteins,  such 
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Figure 26. Activity of the RANTES promoter in PBMCs. 
(A) PBMCs were isolated out of whole blood and seeded onto culture plates. One half was
activated with the mitogen PHA-P (5 µg/ml), the other half was kept untreated as control. 24
hours after activation the cells were transfected with 5 µg hRANTES promoter by
electroporation. 36 hours after the transfection the cells were harvested and luciferase activity
was measured. The levels are expressed as fold change relative to the level of luciferase from
untreated cells. No activity was detected for the promoter transfected into untreated cells, but
the promoter was active in induced cells. 
(B) Activated PBMCs were transfected 5 days after induction by electroporation with 2 µg of the
wildtype (hRANTES) or mutated (mut4hRANTES) hRANTES promoter together with plasmids
encoding m5LEF-1 (2 µg), LEF-1 (6 µg), and b-catenin (10 µg). The levels are expressed as fold
change relative to the level of luciferase from promoter alone. Repression of the wildtype
promoter could be detected after transfection of m5Lef1 or Lef1/β-catenin. The mutated
promoter was shown to get activated by m5LEF-1 and a modest downregulation is seen after
LEF-1 and β-catenin expression. A
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PBMCs but Groucho-1 showed no specific effect (data not shown), implicating that 
the effect observed in M12 cells is not occurring in general, but only appearing in 
special cell types. Therefore, we can say that RANTES is repressed directly by 
LEF-1, probably through an interaction with a specific lymphoid co-repressor, but 
Groucho was not found to participate. 
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Figure 27. Groucho-1 represses the RANTES promoter. M12 cells were transfected with 1
µg mouse RANTES promoter by electroporation together with expression plasmids
encoding for LEF-1 (2 µg), β-catenin (5 µg), and increasing amounts of groucho-1 (1, 3 µg).
Luciferase activities are expressed as fold change relative to the luciferase activity of the
promoter alone. LEF-1 alone and in combination with β-catenin gives only minor effects on
the RANTES promoter, whereas addition of groucho-1 results in a drastic downregulation.
But the regulatory effect does not seem to be mediated by LEF-1 as Groucho-1 can
repress the RANTES promoter on its own. 
mRANTES  +   +   +   +   +   +    +    +    + 
LEF-1   -   +   +   +   +   +    +    -    - 
β-catenin  -   -   +   +   +   -    -    -    - 
groucho-1  -   -   -  
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4.3. Skin 
 
4.3.1. Microarray analysis of skin of E 16.5 wildtype, Lef1-/-, and 
Lef1m5/m5 embryos 
 
4.3.1.1. Probe array hybridization 
 
In our attempt to determine the effects of LEF-1 and search for LEF-1 target 
genes, we wanted to be able to distinguish between effects of LEF-1 arising from 
the canonical Wnt pathway, and regulations apart of the canonical Wnt signaling, 
where the interaction with β-catenin is not important. For this purpose a mouse 
carrying a mutation in the β-catenin interaction domain of LEF-1 (Lef1m5/m5) was 
created in our lab (W. Roth, unpublished data). It was shown by an electro mobility 
shift analysis, that the Lef1m5/m5 mouse can still produce a form of LEF-1 that can 
bind to its consensus sites, but no interaction of LEF-1 with β-catenin is possible. 
The analysis of the Lef1m5/m5 mice revealed that the phenotype is similar to the one 
observed in Lef1-/- mice. The Lef1m5/m5 embryos show also a pointed snout and the 
same lethality as observed for Lef1-/- mice. Nevertheless, the phenotype of the skin 
of Lef1m5/m5 mice is altered as in comparison to Lef1-/- mice and reveals more the 
phenotype of wildtype mice. Lef1-/- mice show, as described before, no mature hair 
follicle. This is due to a developmental block at embryonic stage E17. In contrast to 
the Lef1-/- mice, the Lef1m5/m5 mice show almost normal hair follicle development, 
just in slightly reduced numbers. To further examine the differences between the 
Lef1m5/m5, Lef1-/-, and wildtype mice, and to uncover effects mediated by LEF-1 
without the interaction with β-catenin, we were performing an Affymetrix microarray 
analysis of skin from wildtype, Lef1-/-, and Lef1m5/m5 E16.5 embryos in order to get 
more insight into possible target genes. With this analysis we also hoped to 
encircle the question of repressive effects of LEF-1 and the mechanisms 
underlying the whole process. 
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Whole skin of E16.5 embryos of wildtype, Lef1-/-, and Lef1m5/m5 was prepared and 
total RNA isolated. The RNA was used for microarray analysis with MGU74Avs2 
probe arrays of Affymetrix. The screen of wildtype and Lef1-/- was repeated three 
times with total RNA from different embryos and the labeled RNA was hybridized 
to the probearrays, whereas the Lef1m5/m5 analysis was repeated four times with 
total RNA from different embryos. The microarrays were stained and scanned in 
the Affymetrix fluidics station and scanner. 
 
 
4.3.1.2. Analysis of the probe arrays 
 
To analyze differences between wildtype and Lef1-/- skin, and between wildtype 
and Lef1m5/m5 skin, comparisons for each pair of microarrays were performed, 
using the wildtype as baseline. For the differences between Lef1-/- and Lef1m5/m5 
skin we used Lef1m5/m5 as the baseline, leading us to genes, which are regulated 
by LEF-1 but independently of β-catenin. Setting the criteria to an average of at 
least 3-fold differences in 6 out of 9 comparisons, we could detect 47 genes 
differentially regulated within the Lef1-/- wildtype comparisons, 6 of them being 
repressed, and 39 activated by LEF-1 (Figure 28A, D). For the Lef1m5/m5/wildtype 
comparison, where we analyzed β-catenin dependent activation and repression, 
we were choosing genes that were in average at least 3-fold regulated in 7 out of 
the 12 comparisons. We obtained 86 genes regulated, 8 of them displaying a β-
catenin dependent repression and 78 showing β-catenin dependent activation 
(Figure 28B, D). For the comparison between Lef1-/-/Lef1m5/m5 we could identify 52 
genes, in average at least 3-fold regulated in 6 out of 12 comparisons. 7 of the 
genes displayed β-catenin independent activation, 45 β-catenin independent 
repression (Figure 28C, D). As at least some of the targets found in the two 
screens mutant against wildtype should be overlapping, we were searching for 
genes identified in both comparisons, the comparison Lef1-/-/wildtype and the 
comparison Lef1m5/m5/wildtype. 28 genes were identified in both analyses, 
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indicating that the results we obtained are not random regulations but real LEF-1 
targets. 
  A
 
Lef1-/- vs wildtype 
 
ID# FC Count Description 
1 8.3 7 XXX 
2 4.5 7 XXX 
3 4.5 7 XXX 
4 3.6 8 XXX 
5 3.1 6 XXX 
6 3.1 9 XXX 
7 -2.8 6 XXX 
8 -2.9 6 XXX 
9 -2.9 9 XXX 
10 -2.9 8 XXX 
11 -3.1 9 XXX 
12 -3.4 9 XXX 
13 -3.4 9 XXX 
14 -3.6 9 XXX 
15 -3.6 6 XXX 
16 -3.6 7 XXX 
17 -3.6 6 XXX 
18 -3.7 9 XXX 
19 -3.7 6 XXX 
20 -3.7 7 XXX 
21 -3.7 6 XXX 
22 -3.9 6 XXX 
23 -3.9 6 XXX 
24 -4.0 6 XXX 
25 -4.0 9 XXX 
26 -4.0 6 XXX 
27 -4.1 9 XXX 
28 -4.2 9 XXX 
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29 -4.2 6 XXX 
30 -4.3 6 XXX 
31 -4.3 7 XXX 
32 -4.4 9 XXX 
33 -4.9 9 XXX 
34 -5.0 9 XXX 
35 -5.0 6 XXX 
36 -5.4 8 XXX 
37 -5.8 6 XXX 
38 -5.9 9 XXX 
39 -6.5 7 XXX 
40 -7.0 8 XXX 
41 -7.2 7 XXX 
42 -7.4 9 XXX 
43 -7.5 7 XXX 
44 -7.7 6 XXX 
45 -15.0 9 XXX 
46 -15.5 9 XXX 
47 -17.1 9 XXX 
 
  B
 
Lef1m5/m5 vs wildtype:  
 
ID# FC Count Descriptions 
1 10.3 7 XXX 
48 9.8 7 XXX 
49 5.0 11 XXX 
50 4.8 7 XXX 
6 4.3 7 XXX 
51 3.7 7 XXX 
52 3.5 8 XXX 
53 3.1 9 XXX 
54 -2.8 8 XXX 
55 -2.8 10 XXX 
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56 -2.8 8 XXX 
57 -2.8 8 XXX 
58 -2.8 8 XXX 
43 -2.8 8 XXX 
59 -2.8 7 XXX 
60 -2.9 8 XXX 
61 -2.9 8 XXX 
62 -2.9 7 XXX 
63 -2.9 8 XXX 
64 -3.0 7 XXX 
65 -3.1 7 XXX 
66 -3.2 8 XXX 
67 -3.2 7 XXX 
68 -3.2 8 XXX 
69 -3.2 8 XXX 
70 -3.3 7 XXX 
42 -3.3 11 XXX 
71 -3.3 8 XXX 
72 -3.3 9 XXX 
28 -3.4 12 XXX 
19 -3.4 10 XXX 
73 -3.4 8 XXX 
13 -3.5 9 XXX 
74 -3.5 7 XXX 
18 -3.6 12 XXX 
75 -3.6 8 XXX 
21 -3.6 7 XXX 
76 -3.6 7 XXX 
77 -3.6 8 XXX 
78 -3.7 8 XXX 
79 -3.7 7 XXX 
80 -3.7 8 XXX 
81 -4.0 8 XXX 
82 -4.0 8 XXX 
7 -4.1 10 XXX 
83 -4.1 7 XXX 
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84 -4.3 9 XXX 
85 -4.4 8 XXX 
86 -4.4 8 XXX 
87 -4.5 7 XXX 
40 -4.6 9 XXX 
88 -4.7 7 XXX 
36 -4.7 11 XXX 
27 -4.7 7 XXX 
89 -4.9 8 XXX 
90 -4.9 7 XXX 
91 -5.0 7 XXX 
92 -5.1 7 XXX 
93 -5.2 9 XXX 
94 -5.4 10 XXX 
95 -5.8 8 XXX 
37 -6.0 8 XXX 
96 -6.0 7 XXX 
38 -6.2 10 XXX 
97 -6.5 7 XXX 
15 -6.5 8 XXX 
98 -6.6 7 XXX 
99 -6.6 7 XXX 
25 -7.2 7 XXX 
100 -7.3 9 XXX 
101 -7.3 7 XXX 
29 -7.3 8 XXX 
41 -7.5 10 XXX 
35 -7.9 8 XXX 
11 -8.6 9 XXX 
102 -8.8 7 XXX 
103 -8.8 7 XXX 
34 -9.1 8 XXX 
104 -9.1 7 XXX 
105 -10.3 7 XXX 
106 -11.0 7 XXX 
47 -13.4 12 XXX 
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46 -14.6 12 XXX 
107 -15.2 7 XXX 
45 -24.3 11 XXX 
108 -46.2 7 XXX 
 
  C
 
Lef1-/- vs Lef1m5/m5 
 
ID FC Count Description 
109 13.1 6 XXX 
110 9.6 6 XXX 
111 8.3 6 XXX 
112 8.1 6 XXX 
113 7.7 6 XXX 
114 7.5 6 XXX 
115 7.4 6 XXX 
116 6.7 6 XXX 
117 6.5 6 XXX 
118 6.5 6 XXX 
119 4.3 7 XXX 
120 4.3 6 XXX 
121 4.2 6 XXX 
122 4.2 7 XXX 
123 4.2 6 XXX 
124 4.0 6 XXX 
125 4.0 8 XXX 
126 3.9 6 XXX 
127 3.9 6 XXX 
128 3.9 6 XXX 
129 3.8 6 XXX 
130 3.8 6 XXX 
131 3.7 6 XXX 
132 3.7 6 XXX 
133 3.7 10 XXX 
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134 3.6 6 XXX 
135 3.6 6 XXX 
136 3.6 6 XXX 
137 3.6 6 XXX 
138 3.6 6 XXX 
139 3.4 6 XXX 
140 3.3 6 XXX 
141 3.3 6 XXX 
142 3.3 6 XXX 
143 3.2 7 XXX 
144 3.2 6 XXX 
145 3.2 6 XXX 
146 3.1 6 XXX 
147 3.0 6 XXX 
148 3.0 6 XXX 
149 2.9 6 XXX 
150 2.9 6 XXX 
151 2.9 6 XXX 
152 2.8 6 XXX 
153 2.8 6 XXX 
154 -3.2 6 XXX 
155 -3.5 6 XXX 
156 -4.0 6 XXX 
157 -4.3 11 XXX 
158 -8.8 7 XXX 
159 -8.8 8 XXX 
160 -20.0 12 XXX 
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Figure 28. Identified target genes of the skin microarray screen. 
Accession number (Acc. #) of the identified genes, fold change (FC) as level of regulation, count,
displays in how many comparisons the gene was found to be regulated; name of the gene
(description) are indicated 
(A) Comparison of Lef1-/- versus (vs) wildtype. 41 genes were found to be activated through LEF-1
(negative FC), 6 repressed (positive FC). 
(B) Comparison of Lef1m5/m5 vs wildtype. 76 genes were found to be β-catenin dependent
activated (negative FC), 8 β-catenin dependent repressed (positive FC). 
(C) Comparison of Lef1-/- vs Lef1m5/m5. 45 genes were identified to be β-catenin independent
repressed (positive FC), 7 β-catenin independent activated. 
(D) Schematic overview of the distribution of the different comparisons. 
 
The microarray analyses of the three different mouse lines revealed, that many 
genes are regulated by LEF-1 without the interaction of β-catenin. Those genes 
are mainly genes that get repressed by LEF-1, whereas the majority of genes 
activated by LEF-1 are regulated through the canonical Wnt pathway. 
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5. Discussion 
 
In this analysis we demonstrate that a large number of genes is dependent on 
LEF-1 expression. We were able to identify genes that are positively and 
negatively regulated by LEF-1.  
 
 
5.1. Comparison of the different approaches, used for our 
LEF-1 target gene screens 
 
We could provide evidence that a great variety of genes is regulated by LEF-1 
using three different approaches in our search for LEF-1 target genes. This can be 
explained on the one hand with differences in the expression patterns of the 
identified target genes that vary throughout the tissues, so that a number of genes 
expressed in skin, is for example not expressed in lymphocytes and vice versa. On 
the other hand it may also be a result of different expression patterns of required 
co-activators or co-repressors. But by searching for LEF-1 target genes in T cells 
and skin, the analysis already covered very different tissues and their profiles.  
The T cell screen was carried out with sorted ISP CD8+ cells, helping to minimize 
unspecific effects that are only due to different proportions of the compartments 
what was a great advantage of this approach. 
In our skin analysis we could not reduce the screen to a distinct cell population as 
the skin of E16.5 embryos is too small to be sectioned and analyzed separately. 
But as the skin of the Lef1m5/m5 mutants displays a phenotype closely related to the 
wildtype phenotype, we could neglect those minor effects. For the Lef1-/- skin 
however we had to keep in mind, that some of the genes we wanted to look at are 
probably not expressed in this mutant skin, as the hair follicles are almost 
completely absent. The great advantage of the skin screen was clearly, that we 
could distinguish between β-catenin dependent and β-catenin independent targets, 
as we were using a mouse cell line mutant for the β-catenin interaction domain. 
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Those two loss-of-function experiments were complemented with a gain-of-function 
experiment, where a constitutive active form of LEF-1, a fusion of LEF-1 to the C-
terminal part of β-catenin, was overexpressed in NIH3T3 fibroblasts under 
controlled conditions. Although the target genes identified in the NIH3T3 screen 
depend to some extend on co-activators/repressors that are present in NIH3T3 
cells, this system displays definitely the most cell type independent analysis of the 
three chosen approaches. Another advantage of the cell culture system was, that 
we were able to limit the expression of LEF-1 to a short period of time (eight 
hours), what helped to minimize the number of secondary targets.  
 
 
5.2. Criteria for selection of potential targets 
 
The Affymetrix chip technology is very reproducible and has an intern control for 
unspecific hybridization, consisting of mismatch oligo-nucleotides, where the 
intensity of the perfect match oligo-nucleotide is compared to the mismatch oligo-
nucleotides, having one base of the 21 bases exchanged against another. This 
method ensures reproducible results. The analyses are based on differentially 
expressed genes that differ by a factor of three or more. This changes should be 
significant because a number of genes shows already a functional significant 
change if they are expressed only mono- instead of bi-allelic. Furthermore, the 
experiments were done in multiplex and the regulation had to occur in more than 
half of the comparisons.  
 
 
5.3. Model for repression mediated through LEF-1 
 
The mechanism underlying the repressive effects of LEF-1 is not completely 
understood until today. One recent study showed that LEF-1 together with β-
catenin represses E-cadherin (Jamora 2003). Fuchs and coworkers could provide 
evidence that E-cadherin could not only be downregulated by LEF-1 in the 
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presence of a constitutively stable β-catenin, but that the downregulation of the 
promoter, examined with a promoter analysis, occurred only after LEF-1 and β-
catenin coexpression. However, they could not exclude, that in vivo, the ability of 
LEF-1 and β-catenin to downregulate E-cadherin mRNA expression may be 
indirect. The model of an indirect effect is further supported by findings in the 
chicken feather bud development (Houghton 2003). In this case β-catenin is only 
needed for the onset of Groucho, an identified co-repressor of LEF-1, but not for 
the active process of repression. This could be shown with co-localization studies 
of β-catenin and Groucho. They co-localize only before the repression occurs, but 
the expression pattern during and after the repression is altered and Groucho and 
β-catenin are not found to be expressed in the same compartments. 
To further analyze the difference between the β-catenin dependent and the β-
catenin independent function of LEF-1, we analyzed the skin of Lef1m5/m5, Lef1-/- 
and wildtype mice. The Lef1m5/m5 mouse line was created in our lab, carrying a 
mutation in the β-catenin interaction domain. This results in a shortened LEF-1, 
which cannot interact with β-catenin (W. Roth, unpublished data). As described 
previously, we could observe differences in the hair follicle development of 
Lef1m5/m5 mice and of Lef1-/- mice. Whereas the development of hair follicles is 
blocked in Lef1-/- mice, we could observe hair follicle development of Lef1m5/m5 mice 
at almost normal levels as compared to the wildtype mice. The comparison of skin 
from Lef1m5/m5 to skin from Lef1-/- mice provided us with a number of genes, 
regulated by LEF-1 independently of β-catenin, thus genes that are not regulated 
through the canonical Wnt pathway. Only 7 of the 52 identified target genes were 
found to be genes that get upregulated by LEF-1. Those genes are probably 
regulated in a similar way like TCRα, which is getting induced without the help of β-
catenin (Travis 1991). Nevertheless, the majority of genes regulated without LEF-
1/β-catenin interaction, are genes that are repressed by LEF-1, supporting the 
idea, that co-repressors like Groucho are necessary for the repressive effects 
instead of β-catenin and maybe in very few cases the repression is mediated 
through LEF-1 and β-catenin. This theory was also supported by the comparison of 
wildtype skin with either Lef1-/- skin, or Lef1m5/m5 skin. In both analyses we mainly 
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detected genes that get activated by LEF-1. Although we cannot distinguish 
between β-catenin dependent and independent targets in the wildtype/Lef1-/- 
screen, as LEF-1 is completely abolished, the wildtype/Lef1m5/m5 comparison 
revealed only genes that are regulated with the help of β-catenin, as there is only 
the β-catenin interaction domain missing. For the Lef1m5/m5 comparison we could 
identify more targets (86) as for the Lef1-/- (47), what might be puzzling at the first 
sight, as one expects to see stronger effects after complete withdrawal of LEF-1. 
But there are several explanations for this finding. It is possible that the Lef1m5/m5 
mutant acts on some proteins as dominant negative form of LEF-1 by preventing 
the binding of other LEF/TCF family members. This would lead to more severe 
changes as compared to the Lef1-/- mutant. Nevertheless the phenotype of the 
Lef1m5/m5 is even milder as the one observed for Lef1-/- mice, indicating that the 
dominant negative effect cannot be very pronounced or is acting mainly on genes 
whose deregulation is not resulting in visible phenotypes. The second explanation 
for the discrepancy between those two analyses is that there are some genes 
detected in the wildtype/Lef1m5/m5 comparison that are due to the altered genetic 
background. As the knockout constructs were stably integrated into 129 SV/J 
embryonic stem cells (ES cells) and then injected into C57 BL/6J mice, the genetic 
background is mixed for the first generations. The Lef1-/- knockout is already 
crossed back to C57 BL/6J for many generations, but the Lef1m5/m5 knockout 
mouse is only in the third generation after back cross, so that it is most likely that 
there are some genetic background differences compared to the C57 BL/6J 
wildtype mice. Taken together we can predict that activation processes are most 
likely predominantly mediated through LEF-1 and β-catenin, whereas the majority 
of repressive events seems to be regulated without the help of β-catenin (Figure 
29). 
 
 
5.4. Analysis of validated target genes 
 
The target genes identified are of a great variety in function. The role of some of 
the genes has not been revealed yet, and the knowledge that they are regulated by 
Discussion  107 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 29: Model of activation and repression mediated through LEF-1. 
We predict that activation of target genes is mainly achieved by interaction of LEF-1 with β-catenin
within the canonical Wnt pathway, whereas repression occurs mostly without the help of β-catenin
but with the interplay of LEF-1 and co-repressors like Groucho.  
LEF-1 might help to define their role. We were validating identified genes either 
with northern blot analysis or with real time PCR. The validation showed that the 
genes are to great percentage real targets and the fold change regulations found 
on the microarray are in the right range. For the T cell screen, where we were 
using amplified RNA, the validation was conducted with unamplified RNA, still 
giving the same results as seen on the array. This was also a necessary control 
whether the amplification method we developed was working and the RNA was 
amplified in a linear range.  
To address the question if the connection of the identified targets to LEF-1 is 
meaningful and a direct regulation seems likely, we were studying the genes, their 
expression profiles and promoters, if characterized, to get a sense of the possible 
interplay. 
5.4.1. Targets genes identified in the NIH3T3 screen 
 
The Clathrin light chain B (LCB) is part of the triskelion, a three-legged structure 
that reflects the monomeric form of clathrin. Each leg of the triskelion consists of 
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one heavy chain and two light chains (Kirchhausen 1981; Ungewickell 1981). 
Clathrin coated vesicles are the agents for receptor-mediated transport of 
macromolecules between membrane bound compartments. The promoter of LCB 
is not characterized yet, so we could not perform a search for LEF-1 consensus 
sites. How LEF-1 regulation of the LCB fits in the context with LEF-1, is a question 
difficult to answer, as the precise function of LCB still needs to be uncovered.  
Glycoprotein A15 a member of the TM4SF family that was found to be repressed 
in our NIH3T3 screen, has also no characterized promoter yet. Therefore, an 
analysis for LEF-1 binding site was not possible. But dissecting its function, the 
involvement in differentiation, proliferation, and overexpression in many forms of 
cancer, supports the idea of a regulation by LEF-1. Although this is not a proof for 
interaction it is obvious that A15 is involved in similar processes as LEF-1. A15 is 
abundantly expressed in brain but can also be detected in heart, lung, kidney, 
colon, and muscle (Hosokawa 1999). LEF-1 is not detected in the same 
compartments but is mainly expressed in spleen, thymus, and the lymph nodes. 
Although the expression profiles are not overlapping, this finding still supports the 
regulation of A15 by LEF-1, as this was identified as a downregulated target. The 
absence of A15 in tissues with high levels of LEF-1 points to a strong repression of 
A15 through LEF-1. 
As described before MAGED2 belongs to the big MAGE family. The family 
members share a coiled coil domain, termed MAGE domain and are only 
expressed in a variety of tumors but not in normal cells. As the function of those 
proteins is completely unclear we cannot judge how close the connection between 
LEF-1 and MAGED2 is. 
The oncofetal gene pem is a well characterized protein. It is expressed in a stage-
specific manner during embryonic development. Pem can be detected at high 
levels in T-lymphoma cells and is not detectable in normal lymphoid tissue (Mac 
Leod 1990). Pem encodes a helix-turn-helix (HTH) motif, structural similar to HTH 
transcription factors (Scott 1989). Within our analysis we could see that the 
expression pattern has on the one hand big differences compared to the 
expression pattern of LEF-1, as for example the absence of pem in lymphoid cells, 
but it can be detected in lung in similar regions as LEF-1 (Sasaki 1991). Because 
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pem is also a gene repressed by LEF-1, this findings are as expected, especially 
as the complete signal is lost in our northern blot analysis after CatCLEF 
expression. The gene is alternatively spliced resulting in two different splice 
variants (Maiti 1996) with two different promoters. As the androgen dependent 
promoter was already well characterized (Maiti 1996; Barbulescu 2001) we tested 
if this promoter is active in our cells and is therefore involved in the regulation. By 
PCR reaction we could show that not the splice variant belonging to this promoter 
but the androgen independent one is expressed in the cells used for the screen 
(data not shown). As the androgen independent promoter was not characterized 
yet we could not search for LEF-1 consensus sites to get greater evidence for 
direct regulation of pem through LEF-1. 
Spi2, another target that was found to be repressed by LEF-1, is as described 
before an acute phase reactant that belongs to the protein superfamily of serine 
proteinase inhibitors (serpins). The activity of the spi-2 gene is controlled by 
several regulatory elements located in the promoter region (Simar-Blanchet 1996) 
and by transcriptional repressor sites within the 3’ untranslated region (Paul 1998). 
Screening both elements for LEF-1 binding sites uncovered that the promoter has 
one perfect LEF-1 consensus site, making a direct regulation possible (Figure 
31A). Furthermore showed the study of the 3’ untranslated region three for 
repression important elements (Paul 1998). At least two of the sites show 
homologies to the LEF-1 consensus sequence, suggesting that a direct regulation 
could also be mediated through this silencer. Another support for this theory is that 
the silencer function is not active in NIH3T3 cells, confirming again our findings that 
spi-2 is expressed in the RXR control cell line and loss of the expression occurs 
after LEF-1 induction.  
The IGF-IIR encodes a multifunctional membrane-spanning glycoprotein. It is 
involved in targeting lysosomal enzymes from their sites of synthesis in the Golgi to 
an acidic prelysosomal compartment. The IGF-IIR promoter was already 
characterized (Liu 1995) and showed potential binding sites for c-myc within an E-
box. As we could also find LEF-1 consensus motifs within the sequence (Figure 
31A), two possible regulation processes were hypothesized. On the one hand 
could the regulation be secondary mediated through c-myc, a verified LEF-1 target 
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(He 1998), on the other hand we were testing for direct regulation. Although we 
were trying different methods, transient transfection assays, stable integration, and 
infections we could not detect direct effects on the promoter. This does not mean 
necessarily that the interaction is indirect, it just showed that the regulation is not 
acting through the promoter. It was demonstrated for many other genes that the 
regulation could be provided through enhancer regions that can be placed 
everywhere on the gene as for example the 3’ UTR in the spi-2 gene just 
described, or in the fibroblast growth factor 4 (FGF4) gene, where the regulatory 
element that interacts with LEF-1 was also found in the 3’ UTR (Kratochwil 2002).  
 
 
5.4.2. Target genes identified within the T cell screen 
 
MCP-1 (Yoshimura 1989; Leonard 1990), a cytokine identified in the NIH3T3 
screen and RANTES (Schall 1988), a cytokine identified within the T cell analysis, 
belong to the same family of chemokines. The superfamily of small proteins 
consists of about 50 so far identified proteins. These molecules share a secondary 
structure with a flexible N-terminal segment followed by three antiparallel β-sheets, 
and a C-terminal α-helix. According to the position of the cysteine residues they 
have been subdivided in four families: CXC, CC, C, and CX3C (Zlotnik 2000). The 
chemokines activate a family of seven transmembrane G protein-coupled 
receptors, called chemokine receptors (Murphy 1996). Both identified target genes 
belong to the CC chemokine family and are located on the same chromosome 
cluster. They share overlapping functions and belong to the inducible form of CC 
chemokines that are made in response to diverse signals. The first function that 
was uncovered was their ability to recruit leukocytes on demand, in response to 
inflammatory, infectious, and immunological signals. Furthermore have recent 
investigations shown that they also play an important role in T cell differentiation 
(Luther 2001). As they only start to play a role in already matured T cells where 
LEF-1 is not expressed any more this finding is not contradictionary to the finding 
that LEF-1 represses both chemokines. Moreover we were analyzing if the 
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induction of RANTES in stimulated PBMCs was triggered by the absence of LEF-1. 
Our data suggest as LEF-1 is in all stages of stimulated PBMCs only weakly 
expressed, that the discontinuation of a repressor does not lead necessarily to 
upregulation of the gene. This can be easily explained by the fact that regulatory 
processes are mostly not simple, but they consist of a network of negative and 
positive stimuli. In this case there is RFLAT needed as a positive factor to obtain 
the upregulation of RANTES (Song 1999).  
Search of the MCP-1 and RANTES promoter for LEF-1 consensus sites revealed 
that MCP-1 has one strong and several weaker LEF-1 consensus sites (Figure 
31A). As the promoter region of RANTES is not conserved between mouse and 
human we studied both and could show by EMSA, binding of LEF-1 to two sites of 
the mouse promoter. For the human promoter strong binding to two sites and 
weaker binding to two additional sites was proven. The cumulative appearance of 
LEF-1 binding sites in the different chemokine promoters raises the question, if 
there are more members of the inducible CC chemokine family regulated through 
LEF-1, than the so far discovered MCP-1 and RANTES.  
As a model for the regulation of CC chemokines we performed a more detailed 
analysis of the RANTES gene. First we were checking the endogenous RANTES 
levels in Jurkat and Hut78 cell lines. It appeared that RANTES was highly 
expressed in cell lines where almost no LEF-1 is expressed and vice versa. Those 
findings of endogenous regulations motivated us to dissect the mouse and the 
human promoter in a promoter analysis. Although the mouse promoter is active in 
the human T cell line Hut78, we could detect only a very weak response to LEF-1 
and β-catenin overexpression. In NIH3T3 fibroblast we could discover activation of 
the mouse RANTES promoter. But this activation was not mediated through the 
LEF-1 binding sites as it was still occurring when transfecting the truncated 
construct of the RANTES promoter, which is missing all LEF-1 binding sites. Next 
we were also testing the human promoter, as there was the possibility that there 
were differences in the regulation because of the diversity between human and 
mouse and we were carrying out most experiments in human cells. The human 
promoter could be shown to be downregulated up to two fold in Hut78 cells and 
PBMCs. Further analysis of the repression in PBMCs revealed that we could 
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observe an upregulation after m5LEF-1 expression for the mutated promoter in 
contrast to the repressive effects detectable with the wildtype promoter. This might 
be due to secondary activating effects that we also could observe in NIH3T3 cells. 
The network of direct repressive and indirect activating effects can be explained by 
the fact that in vivo LEF-1 is not expressed in the cell types examined. Therefore, 
the direct repressive effect of LEF-1 has to overcome the diametrical indirect 
activation observed. The fact that in NIH3T3 cells the activation is also observed 
for the wildtype promoter suggests that LEF-1 has to interact with a co-repressor 
not expressed in NIH3T3 cells (Figure 30). Organization 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 30. Model for regulatory effects affecting RANTES promoter activity. 
In PBMC’s LEF-1 mediates directly the downregulation of the RANTES promoter through its LEF-
1 binding sites together with a co-repressor. The effect is weakened by a secondary unnatural 
effect of LEF-1 on an activator, which can upregulate RANTES. The mutated RANTES promoter, 
missing the four LEF-1 binding sites, can not get repressed by LEF-1 due to the absence of 
binding sites and the secondary, positive effect is observed. In NIH3T3 cells, the necessary co-
repressor is missing and wildtype and mutated promoter are detected upregulated due to the 
secondary effector.  
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As the downregulation already occurred after expression of m5LEF-1 and β-catenin 
was not necessary, but the help of a co-repressor was most likely, taking the 
results of the NIH3T3 cells into account, we were examining the effects of 
Groucho-1 addition. Nevertheless, RANTES was not responding specific to LEF-1 
and Groucho but in M12 cells a repression could be achieved already with 
Groucho alone. We could not delineate if this effect is specific or not.  
Taken together we could provide evidence of specific repression of the RANTES 
promoter through LEF-1, although we could not identify a co-repressor. But as 
predicted in our model (Figure 29), the repression is mediated without the 
interaction of β-catenin. 
The second repressed gene that we identified and validated in our T cell screen is 
FasL (Pinkoski 1999), a tumor necrosis facto (TNF) related type II membrane 
protein. It can bind to Fas and is expressed in highly activated T-lymphocytes 
(Nagata 1999). FasL and Fas are mediators of apoptosis and can downregulate 
the immune response. In an analysis of developing B cells of wildtype and Lef1-/-, it 
was shown that Fas is deregulated (Reya 2000). With the T cell screen we now 
identified the interplayer of Fas, FasL to be regulated. FasL is also known to be a 
marker for apoptosis (Brunner 1995; Nagata 1999). By identifying Fas and FasL in 
two different studies and different tissues, it becomes most likely that the Fas/FasL 
expression levels in all tissues are strongly depending on LEF-1 expression. This 
theory is supported by the identification of one potential LEF-1 binding sites in the 
FasL promoter (Figure 31A). As for RANTES it could be shown for FasL that its 
endogenous levels are only high in cell lines expressing low levels of LEF-1. 
One of the two validated activated genes in our T cell screen is SATB1, a MAR-
binding protein that was shown to regulate expression of multiple genes during T-
cell development. Mice, sufficient for SATB1, also develop a T cell block, but this 
block occurs later in development as seen for the Lef1-/-Tcf1(V)-/- mice (Alvarez 
2000), making it most likely that SATB1 is downstream of LEF-1. Another evidence 
for this model was provided by Matsuzaki and co-workers. They could provide 
evidence, that the Drosophila homolog of the Satb genes, Dve, is regulated by 
Decapentaplegic (Dpp), the Drosophila homolog of BMP4, or Wingless (Wg), the 
Drosophila homolog of Wnt within different target cells of the gut (Nakagoshi 1998). 
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Dve expression responds differentially to either of them in distinct parts of the 
midgut. In the middle midgut, dve expression was shown to depend mainly on Dpp. 
This analysis was conducted with abdominal-A (abd-A) mutants, where the Dpp 
but no Wg is expressed. Nevertheless dve could still be detected in the middle 
midgut. In contrast, the dve expression in the anterior-most midgut depends on 
Wg, but not on Dpp. A mutant fly that does not express Wg in this region was 
found to also have no dve expression. It could be strong evidence provided, that at 
least in some target cell the regulation of the Satb homolog is regulated through 
Wg, respectively Wnt. This is in line with our observation, that SATB1 is found to 
be activated by LEF-1, as most of the activating processes of LEF-1 are mediated 
through the Wnt signaling pathway. 
For SATB1 several different EST variants can be found in the database, sharing all 
the second exon, but showing different non-coding first exons (Figure 31B), 
resulting in different splice variants but the same translated protein. This can be 
necessary to obtain a diverse regulation in different tissues as it was also observed 
for Dve. We could identify 4 different exon 1 for the mouse and the human SATB1. 
As there are more than 20 kb between the different first exons, we concluded that 
there are most likely at least four different promoters. None of them is 
characterized yet, but by searching upstream of the putative 5’ end of the different 
exon 1, we could identify several LEF-1 binding sites upstream of one of the splice 
variants (Figure 31B). The other two putative promoter regions did not have any 
LEF-1 binding sites, reinforcing the theory, that the regulation of SATB1 is cell type 
specific. The control of endogenous levels in different cell lines revealed that 
SATB1 is highly expressed in cell lines that also have high LEF-1 levels. To reduce 
the possibility that SATB1 is only a secondary target we could show in a 
transfection assay that already 12 hours after transfection of Lef1 and β-catenin the 
endogenous levels of SATB1 are up-regulated more than 8-fold. For a homologue 
of SATB1, termed SATB2, that was identified in our lab (G. Dobreva, unpublished 
data), an upregulation of the endogenous levels was also detected when tested 
after 24 hours. This finding suggests that not only SATB1 is a target of LEF-1 but 
that also SATB2 is regulated by LEF-1. As the induction time of 12 hours for 
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protein production is quite short, this finding strongly indicates that the regulations 
of SATB1/2 are tightly connected to LEF-1 and are most likely direct. 
CD5, the second validated gene of the T cell screen that was found to be activated, 
is a pan-T marker present on helper T cell and on suppressor or cytotoxic T cells. 
CD5 function is still unclear, but a function in T cell proliferation was suggested 
(Hollander 1981; Loydberg 1985). CD5 was identified in a T cell analysis before 
(Okamura 1998). There a downregulation was examined in Lef1-/-Tcf1(V)-/- mice in 
comparison to wildtype mice. But as the northern blot of this analysis was 
performed out of unsorted thymic cells, the effect was accounted to the absence of 
later stages of T cells and the change of the compartment. As outlined before we 
have performed the analysis with sorted cells, just to rule out any secondary effects 
due to the changed cell populations. But as we can still detect differences of CD5 
expression between wildtype and Lef1-/-Tcf1(V)-/- mice, we can predict that the 
changes are really due to the withdrawal of LEF-1/TCF-1. Although the analysis of 
the promoter did not show any good LEF-1 binding sites (Figure 30B), we were 
testing the endogenous regulation after transfection of Lef1 and β-catenin. As seen 
for SATB1 we could also detect a more than 12-fold upregulation of CD5 after 12 
hours. This again indicated a tight regulation of CD5 through LEF-1. 
 
Most of the genes validated could be shown to have either LEF-1 binding sites in 
the promoter, or to have similar functions and expression profiles as LEF-1. Taken 
together the identified target genes are mostly involved in essential processes, and 
the knowledge of a regulation through LEF-1 will help to define their role more 
precisely in the future. 
 
 
5.4.3. Target genes identified within the skin screen 
 
We did not validate genes of the skin microarray analysis so far. Nevertheless we 
could identify in this analysis a number of very interesting targets as for example 
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Figure 30. Promoters and genomic organization of the validated genes.  
(A)The characterized promoters of the validated genes of both screens were searched for LEF-1
binding sites. The strong LEF-1 binding sites are indicated in dark red, the weaker binding sites in
light red. For the spi2 LEF-1 binding sites could be detected in the promoter region and in the 3’
UTR. +1 indicates the transcription start site.  
(B) Scheme of the genomic organization of the 5’ region of mouse SATB1. The different exons are
indicated by numbers (1a-2). Distances between the different exons are given as kilobases. The
putative exon of splice variant 1d is indicated with the LEF-1 binding sites. 
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BMP2 that was found to be positively regulated through LEF-1 and β-catenin. Many 
studies already revealed that there is a connection between the BMP and the Wnt 
signaling pathway, as for example the study of Birchmeier and coworkers 
(Soshnikova 2003), where they describe the interplay of the Wnt/β-catenin and 
BMP signaling during the formation of the apical ectodermal ridge (AER) and of the 
dorsal-ventral axis of the limbs. They come to the conclusion that in the AER 
formation β-catenin acts downstream of the BMP, but upstream or in parallel by the 
dorsal-ventral patterning. Moreover it was shown recently that the BMP receptors, 
termed Smad, can directly interact with Dishevelled-1, a positively regulator of the 
Wnt signaling (Warner 2003). Another study could show that LEF-1 can regulate 
BMP-target genes synergistically through the interaction with Smads (Hussein 
2003). Those findings make a further analysis of BMP-2 very interesting as it could 
provide another level of cross-talk between the Wnt and the BMP signaling.  
 
Taken together the studies give a great overview of the diversity of LEF-1 
regulated processes in the cell. It shows that many pathways are maybe closer 
linked than suggested so far. We could also provide evidence for the different 
functions of LEF-1, acting either as an activator or as a repressor. Many of the 
targets are promising targets and should be subjects of further analysis.  
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6. Summary 
 
In this analysis we were able to provide great insight into many genes regulated by 
LEF-1. We encircled the question for LEF-1 target genes from three directions. 
One gain of function experiment, where we overexpressed a constitutive active 
form of LEF-1, and two loss of function experiments, where we compared different 
forms of LEF-1 mutant mice with wildtype mice, were accomplished. All 
approaches were conducted with Affymetrix chip technology. 
On the one hand we could identify many target genes that were differentially 
expressed in NIH3T3 cells overexpressing CatCLEF in comparison to a control cell 
line without CatCLEF expression. Nine of the identified genes, Clathrin light chain, 
Glycoprotein A15, MAGE D2, pem, Spi2, IGF-IIR, and MCP-1, were validated by 
northern blot analysis.  
On the other hand, we were able to find LEF-1 target genes in sorted ISP CD8+ T 
cells, comparing wildtype and Lef1-/-Tcf1(V)-/- cells. Four genes, SATB1, CD5, 
FasL, and RANTES, were validated and we could show that the endogenous 
expression levels in cell lines revealed the regulation observed. After 
overexpression of LEF-1 and β-catenin in a LEF-1 negative T cell line, we could 
show that endogenous levels of SATB1 and CD5 were induced. Furthermore, we 
could provide evidence that LEF-1 is able to bind within the RANTES promoter 
region and thus can directly repress the RANTES promoter. This effect is 
mediated β-catenin independent by LEF-1. 
As a third approach we were investigating the differences between regulations 
mediated through the interaction of LEF-1 and β-catenin and regulations occurring 
without β-catenin interaction. Therefore we were performing a screen of skin from 
wildtype, Lef1-/-, and Lef1m5/m5 E16.5 embryos. The analysis showed that most of 
the activating events are mediated through the canonical Wnt pathway, where 
LEF-1 and β-catenin interact. However, the greater number of repressive effects is 
happening without β-catenin cooperation. 
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